1
|
Skurikhin E, Ermakova N, Zhukova M, Pan E, Widera D, Sandrikina L, Kogai L, Pershina O, Pakhomova A, Pan VY, Kushlinskii N, Kubatiev A, Morozov S, Dygai A. Effects of reprogrammed splenic CD8 + T-cells in vitro and in mice with spontaneous metastatic Lewis lung carcinoma. BMC Cancer 2024; 24:522. [PMID: 38664641 DOI: 10.1186/s12885-024-12203-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 03/28/2024] [Indexed: 04/28/2024] Open
Abstract
BACKGROUND Metastatic disease is a major and difficult-to-treat complication of lung cancer. Considering insufficient effectiveness of existing therapies and taking into account the current problem of lung cancer chemoresistance, it is necessary to continue the development of new treatments. METHODS Previously, we have demonstrated the antitumor effects of reprogrammed CD8+ T-cells (rCD8+ T-cells) from the spleen in mice with orthotopic lung carcinoma. Reprogramming was conducted by inhibiting the MAPK/ERK signalling pathway through MEKi and the immune checkpoint PD-1/PD-L1. Concurrently, CD8+ T-cells were trained in Lewis lung carcinoma (LLC) cells. We suggested that rCD8+ T-cells isolated from the spleen might impede the development of metastatic disease. RESULTS The present study has indicated that the reprogramming procedure enhances the survival and cytotoxicity of splenic CD8+ T-cells in LLC culture. In an LLC model of spontaneous metastasis, splenic rCD8 + T-cell therapy augmented the numbers of CD8+ T-cells and CD4+ T-cells in the lungs of mice. These changes can account for the partial reduction of tumors in the lungs and the mitigation of metastatic activity. CONCLUSIONS Our proposed reprogramming method enhances the antitumor activity of CD8+ T-cells isolated from the spleen and could be valuable in formulating an approach to treating metastatic disease in patients with lung cancer.
Collapse
Affiliation(s)
- E Skurikhin
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia.
| | - N Ermakova
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia
- Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028, Tomsk, Russia
| | - M Zhukova
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia.
| | - E Pan
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia
| | - D Widera
- Stem Cell Biology and Regenerative Medicine Group, School of Pharmacy, Whiteknights Campus, RG6 6AP, Reading, UK
| | - L Sandrikina
- Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028, Tomsk, Russia
| | - L Kogai
- Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028, Tomsk, Russia
- Ministry of Health of the Russian Federation, Siberian State Medical University, Moskovski, 2, 634050, Tomsk, Russia
| | - O Pershina
- Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028, Tomsk, Russia
| | - A Pakhomova
- Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028, Tomsk, Russia
| | - V Yu Pan
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia
| | - N Kushlinskii
- Blokhin National Medical Research Center of Oncology, 115522, Moscow, Russia
| | - A Kubatiev
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia
| | - S Morozov
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia
| | - A Dygai
- Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia
- Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028, Tomsk, Russia
| |
Collapse
|
2
|
Visaggi P, Ghisa M, Barberio B, Chiu PW, Ishihara R, Kohn GP, Morozov S, Thompson SK, Wong I, Hassan C, Savarino EV. Gastro-esophageal diagnostic workup before bariatric surgery or endoscopic treatment for obesity: position statement of the International Society of Diseases of the Esophagus. Dis Esophagus 2024:doae006. [PMID: 38281990 DOI: 10.1093/dote/doae006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Accepted: 01/03/2024] [Indexed: 01/30/2024]
Abstract
Obesity is a chronic and multifactorial condition characterized by abnormal weight gain due to excessive adipose tissue accumulation that represents a growing worldwide challenge for public health. In addition, obese patients have an increased risk of hiatal hernia, esophageal, and gastric dysfunction, as well as gastroesophageal reflux disease, which has a prevalence over 40% in those seeking endoscopic or surgical intervention. Surgery has been demonstrated to be the most effective treatment for severe obesity in terms of long-term weight loss, comorbidities, and quality of life improvements and overall mortality decrease. The recent emergence of bariatric endoscopic techniques promises less invasive, more cost-effective, and reproducible approaches to the treatment of obesity. With the endorsement of the International Society for Diseases of the Esophagus, we started a Delphi process to develop consensus statements on the most appropriate diagnostic workup to preoperatively assess gastroesophageal function before bariatric surgical or endoscopic interventions. The Consensus Working Group comprised 11 international experts from five countries. The group consisted of gastroenterologists and surgeons with a large expertise with regard to gastroesophageal reflux disease, bariatric surgery and endoscopy, and physiology. Ten statements were selected, on the basis of the agreement level and clinical relevance, which represent an evidence and experience-based consensus of the International Society for Diseases of the Esophagus.
Collapse
Affiliation(s)
- Pierfrancesco Visaggi
- Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
- Digestive Endoscopy Unit, Pisa University Hospital, Pisa, Italy
| | - Matteo Ghisa
- Digestive Endoscopy Unit, Department of Gastroenterology, Padua University Hospital, Padua, Italy
| | - Brigida Barberio
- Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
| | - Philip W Chiu
- Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| | - Ryu Ishihara
- Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Geoffrey P Kohn
- Department of Surgery, Monash University Eastern Health Clinical School, Melbourne, Australia
- Melbourne Upper GI Surgical Group, c/o Cabrini Hospital, Malvern, Australia
| | - Sergey Morozov
- Department of Gastroenterology, Hepatology and Nutrition, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russia
| | - Sarah K Thompson
- College of Medicine & Public Health, Flinders University, Bedford Park, Australia
| | - Ian Wong
- Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| | - Cesare Hassan
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- Department of Biomedical Sciences, Endoscopy Unit, IRCCS Humanitas Clinical and Research Center, Milan, Italy
| | - Edoardo Vincenzo Savarino
- Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
- Gastroenterology Unit, Azienda Ospedale Università of Padua, Padua, Italy
| |
Collapse
|
3
|
Strekalova T, Svirin E, Gorlova A, Sheveleva E, Burova A, Khairetdinova A, Sitdikova K, Zakharova E, Dudchenko AM, Lyundup A, Morozov S. Resilience and Vulnerability to Stress-Induced Anhedonia: Unveiling Brain Gene Expression and Mitochondrial Dynamics in a Mouse Chronic Stress Depression Model. Biomolecules 2023; 13:1782. [PMID: 38136653 PMCID: PMC10741640 DOI: 10.3390/biom13121782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 12/07/2023] [Accepted: 12/09/2023] [Indexed: 12/24/2023] Open
Abstract
The role of altered brain mitochondrial regulation in psychiatric pathologies, including Major Depressive Disorder (MDD), has attracted increasing attention. Aberrant mitochondrial functions were suggested to underlie distinct inter-individual vulnerability to stress-related MDD syndrome. In this context, insulin receptor sensitizers (IRSs) that regulate brain metabolism have become a focus of recent research, as their use in pre-clinical studies can help to elucidate the role of mitochondrial dynamics in this disorder and contribute to the development of new antidepressant treatment. Here, following 2-week chronic mild stress (CMS) using predation, social defeat, and restraint, MDD-related behaviour and brain molecular markers have been investigated along with the hippocampus-dependent performance and emotionality in mice that received the IRS dicholine succinate (DS). In a sucrose test, mice were studied for the key feature of MDD, a decreased sensitivity to reward, called anhedonia. Based on this test, animals were assigned to anhedonic and resilient-to-stress-induced-anhedonia groups, using a previously established criterion of a decrease in sucrose preference below 65%. Such assignment was based on the fact that none of control, non-stressed animals displayed sucrose preference that would be smaller than this value. DS-treated stressed mice displayed ameliorated behaviours in a battery of assays: sucrose preference, coat state, the Y-maze, the marble test, tail suspension, and nest building. CMS-vulnerable mice exhibited overexpression of the inflammatory markers Il-1β, tnf, and Cox-1, as well as 5-htt and 5-ht2a-R, in various brain regions. The alterations in hippocampal gene expression were the closest to clinical findings and were studied further. DS-treated, stressed mice showed normalised hippocampal expression of the plasticity markers Camk4, Camk2, Pka, Adcy1, Creb-ar, Nmda-2r-ar, and Nmda-2r-s. DS-treated and non-treated stressed mice who were resilient or vulnerable to anhedonia were compared for hippocampal mitochondrial pathway regulation using Illumina profiling. Resilient mice revealed overexpression of the mitochondrial complexes NADH dehydrogenase, succinate dehydrogenase, cytochrome bc1, cytochrome c oxidase, F-type and V-type ATPases, and inorganic pyrophosphatase, which were decreased in anhedonic mice. DS partially normalised the expression of both ATPases. We conclude that hippocampal reduction in ATP synthesis is associated with anhedonia and pro-inflammatory brain changes that are ameliorated by DS.
Collapse
Affiliation(s)
- Tatyana Strekalova
- Division of Molecular Psychiatry, Center of Mental Health, University of Hospital Würzburg, 97080 Wuerzburg, Germany
| | - Evgeniy Svirin
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Anna Gorlova
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Elizaveta Sheveleva
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Alisa Burova
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Adel Khairetdinova
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Kseniia Sitdikova
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Elena Zakharova
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Alexander M. Dudchenko
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| | - Aleksey Lyundup
- Endocrinology Research Centre, Dmitry Ulyanov St. 19, Moscow 117036, Russia;
- Research and Education Resource Center, Peoples Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya St, Moscow 117198, Russia
| | - Sergey Morozov
- Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia (A.G.); (E.S.); (A.B.); (A.K.); (K.S.); (E.Z.); (A.M.D.); (S.M.)
| |
Collapse
|
4
|
Kolesov D, Astakhova A, Galdobina M, Moskovtsev A, Kubatiev A, Sokolovskaya A, Ukrainskiy L, Morozov S. Scanning Probe Microscopy Techniques for Studying the Cell Glycocalyx. Cells 2023; 12:2778. [PMID: 38132098 PMCID: PMC10741541 DOI: 10.3390/cells12242778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 11/01/2023] [Accepted: 11/28/2023] [Indexed: 12/23/2023] Open
Abstract
The glycocalyx is a brush-like layer that covers the surfaces of the membranes of most cell types. It consists of a mixture of carbohydrates, mainly glycoproteins and proteoglycans. Due to its structure and sensitivity to environmental conditions, it represents a complicated object to investigate. Here, we review studies of the glycocalyx conducted using scanning probe microscopy approaches. This includes imaging techniques as well as the measurement of nanomechanical properties. The nanomechanics of the glycocalyx is particularly important since it is widely present on the surfaces of mechanosensitive cells such as endothelial cells. An overview of problems with the interpretation of indirect data via the use of analytical models is presented. Special insight is given into changes in glycocalyx properties during pathological processes. The biological background and alternative research methods are briefly covered.
Collapse
Affiliation(s)
- Dmitry Kolesov
- Moscow Polytechnic University, 107023 Moscow, Russia
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
| | - Anna Astakhova
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
| | - Maria Galdobina
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
| | - Alexey Moskovtsev
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
| | - Aslan Kubatiev
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
| | - Alisa Sokolovskaya
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
| | - Leonid Ukrainskiy
- Mechanical Engineering Research Institute of the Russian Academy of Sciences, 119334 Moscow, Russia
| | - Sergey Morozov
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
| |
Collapse
|
5
|
Utochkin V, Kudryavtsev K, Rumyantsev V, Fadeev M, Razova A, Mikhailov N, Shengurov D, Gusev S, Gusev N, Morozov S. Mid-IR lasing in HgCdTe multiple quantum well edge-emitting ridges. Appl Opt 2023; 62:8529-8534. [PMID: 38037965 DOI: 10.1364/ao.504295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Accepted: 10/15/2023] [Indexed: 12/02/2023]
Abstract
Thin HgCdTe/CdHgTe quantum wells (QWs) grown on alternative GaAs (013) substrates have been recently proposed as a material for coherent emitters in the mid-IR region. In this work, we develop a technological process for the fabrication of ridge microresonators in waveguide heterostructures with multiple HgCdTe QWs via photolithography and ion etching. We process two samples with different ridge heights and analyze their emission spectra measured under optical excitation. The width of the emission spectra dropped by an order of magnitude compared to the nonprocessed as-grown structure, allowing one to conclude that lasing at 9.2-7.1 µm takes place within the 8-120 K temperature range. However, both samples demonstrated faster temperature quenching of lasing than that of the single-pass stimulated emission from the nonprocessed structure, as well as a drop in the carrier lifetimes. These figures of merit are likely to be compromised not by the Q factor of the cavities, but due to defects induced during the etching process. Finally, the implications for HgCdTe-based lasers for the 3-5 µm transparency window and longer wavelengths (beyond 20 µm) are discussed.
Collapse
|
6
|
Pavlov D, Gorlova A, Haque A, Cavalcante C, Svirin E, Burova A, Grigorieva E, Sheveleva E, Malin D, Efimochkina S, Proshin A, Umriukhin A, Morozov S, Strekalova T. Maternal Chronic Ultrasound Stress Provokes Immune Activation and Behavioral Deficits in the Offspring: A Mouse Model of Neurodevelopmental Pathology. Int J Mol Sci 2023; 24:11712. [PMID: 37511470 PMCID: PMC10380915 DOI: 10.3390/ijms241411712] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 07/09/2023] [Accepted: 07/16/2023] [Indexed: 07/30/2023] Open
Abstract
Neurodevelopmental disorders stemming from maternal immune activation can significantly affect a child's life. A major limitation in pre-clinical studies is the scarcity of valid animal models that accurately mimic these challenges. Among the available models, administration of lipopolysaccharide (LPS) to pregnant females is a widely used paradigm. Previous studies have reported that a model of 'emotional stress', involving chronic exposure of rodents to ultrasonic frequencies, induces neuroinflammation, aberrant neuroplasticity, and behavioral deficits. In this study, we explored whether this model is a suitable paradigm for maternal stress and promotes neurodevelopmental abnormalities in the offspring of stressed females. Pregnant dams were exposed to ultrasound stress for 21 days. A separate group was injected with LPS on embryonic days E11.5 and E12.5 to mimic prenatal infection. The behavior of the dams and their female offspring was assessed using the sucrose test, open field test, and elevated plus maze. Additionally, the three-chamber sociability test and Barnes maze were used in the offspring groups. ELISA and qPCR were used to examine pro-inflammatory changes in the blood and hippocampus of adult females. Ultrasound-exposed adult females developed a depressive-like syndrome, hippocampal overexpression of GSK-3β, IL-1β, and IL-6 and increased serum concentrations of IL-1β, IL-6, IL-17, RANTES, and TNFα. The female offspring also displayed depressive-like behavior, as well as cognitive deficits. These abnormalities were comparable to the behavioral changes induced by LPS. The ultrasound stress model can be a promising animal paradigm of neurodevelopmental pathology associated with prenatal 'emotional stress'.
Collapse
Affiliation(s)
- Dmitrii Pavlov
- Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| | - Anna Gorlova
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| | - Abrar Haque
- Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada
| | - Carlos Cavalcante
- Department of Human Health and Science, MacEwan University, Edmonton, AB T5J 4S2, Canada
| | - Evgeniy Svirin
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| | - Alisa Burova
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| | - Elizaveta Grigorieva
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| | - Elizaveta Sheveleva
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| | - Dmitry Malin
- Laboratory of Psychiatric Neurobiology, Department of Normal Physiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | - Sofia Efimochkina
- Laboratory of Psychiatric Neurobiology, Department of Normal Physiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | - Andrey Proshin
- P.K. Anokhin Research Institute of Normal Physiology, 125315 Moscow, Russia
| | - Aleksei Umriukhin
- Laboratory of Psychiatric Neurobiology, Department of Normal Physiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | - Sergey Morozov
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| | - Tatyana Strekalova
- Laboratory of Cognitive Dysfunctions, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315 Moscow, Russia
| |
Collapse
|
7
|
Morozov S, Pilipenko V, Goncharov A, Sasunova A, Isakov V. P27-024-23 Spread Enriched With 5-Hydroxytryptophan, Theanine and Gamma-Aminobutyric Acid Improves Mental Performance in Healthy Subjects: Data of Pilot Randomized Controlled Trial. Curr Dev Nutr 2023; 7:101231. [DOI: 10.1016/j.cdnut.2023.101231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2024] Open
|
8
|
Morozov S, Batskikh S. Commentary: Hepatitis B virus infection: an insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Front Immunol 2023; 14:1200405. [PMID: 37266431 PMCID: PMC10229800 DOI: 10.3389/fimmu.2023.1200405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Accepted: 05/02/2023] [Indexed: 06/03/2023] Open
Affiliation(s)
- Sergey Morozov
- Department of Gastroenterology, Hepatology and Nutrition, Federal Research Center of Nutrition and Biotechnology, Moscow, Russia
| | - Sergey Batskikh
- Department of Hepatology, Moscow Clinical Scientific Center n.a. A.S. Loginov, Moscow, Russia
| |
Collapse
|
9
|
Ivashkin A, Abdurashitov D, Baranov A, Guber F, Morozov S, Musin S, Strizhak A, Tkachev I. Testing entanglement of annihilation photons. Sci Rep 2023; 13:7559. [PMID: 37160981 PMCID: PMC10170125 DOI: 10.1038/s41598-023-34767-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Accepted: 05/07/2023] [Indexed: 05/11/2023] Open
Abstract
We present a new experimental study of the quantum entanglement of photon pairs produced in positron-electron annihilation at rest. Each annihilation photon has an energy that is five orders of magnitude higher than the energy of photons in optical experiments. It provides a unique opportunity for controlled Compton pre-scattering of initial photons before the polarization measurements. The experimental setup includes a system of Compton polarimeters to measure the angular correlations of annihilation photons in initial and thus prepared pre-scattered states. For the first time, a direct comparison of the polarization correlations of initial and pre-scattered annihilation photons has been carried out. The angular distributions of scattered in polarimeters photons turned out to be the same for both types of events. Moreover, the correlation function in the Bell's inequality is also the same for both states. We discuss the implications of our results for quantum measurement theory and for the quantum-entangled positron emission tomography.
Collapse
Affiliation(s)
| | | | - Alexander Baranov
- Institute for Nuclear Research RAS, Moscow, 117312, Russia
- National Research Nuclear University MEPhI, Moscow, 115409, Russia
| | - Fedor Guber
- Institute for Nuclear Research RAS, Moscow, 117312, Russia
| | - Sergey Morozov
- Institute for Nuclear Research RAS, Moscow, 117312, Russia
| | - Sultan Musin
- Institute for Nuclear Research RAS, Moscow, 117312, Russia
- Moscow Institute of Physics and Technology, Moscow, 141701, Russia
| | - Alexander Strizhak
- Institute for Nuclear Research RAS, Moscow, 117312, Russia
- Moscow Institute of Physics and Technology, Moscow, 141701, Russia
| | - Igor Tkachev
- Institute for Nuclear Research RAS, Moscow, 117312, Russia
| |
Collapse
|
10
|
Morozov S, Vorozhko I, Isakov V. EP52 SERUM CONCENTRATION OF NEUROKININ A AND SUBSTANCE P CORRELATE WITH ESOPHAGEAL FUNCTION TESTING PARAMETERS IN SUBJECTS WITH GASTROESOPHAGEAL REFLUX DISEASE. Gastroenterology 2023; 164:S-1201. [DOI: 10.1016/s0016-5085(23)03773-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/03/2024]
|
11
|
Shegay P, Leontyev A, Baranovskii D, Davydov G, Poluektova M, Grivtsova L, Petriev V, Stepanenko V, Gulidov I, Krylov V, Osadchaya S, Petrov V, Sedova M, Vekilyan M, Krasilnikova O, Morozov S, Ivanov S, Klabukov I, Kaprin A. World's First Experience of the Low-dose radionuclide inhalation therapy in the treatment of COVID-19-associated viral pneumonia: phase 1/2 clinical trial. Curr Radiopharm 2023:CRP-EPUB-130033. [PMID: 36880188 DOI: 10.2174/1874471016666230307113045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Revised: 12/13/2022] [Accepted: 01/04/2023] [Indexed: 03/08/2023]
Abstract
OBJECTIVE Previously, the 99mTc inhalation was used for pneumonia treatment that decreases inflammation and disease severity. We aimed to investigate the safety and effectiveness of carbon nanoparticles labeled with Technetium isotope (99mTc) in a form of ultradispersed aerosol in combination with standard COVID-19 therapy. The study was a randomized phase 1 and phase 2 clinical trial of low-dose radionuclide inhalation therapy for patients with COVID-19 related pneumonia. METHOD We enrolled 47 patients with confirmed COVID-19 infection and early laboratory signs of cytokine storm and randomized them into the Treatment and Control groups. We analyzed blood parameters reflecting the COVID-19 severity and inflammatory response. RESULTS Low-dose 99mTc-labeled inhalation showed a minimal accumulation of radionuclide in lungs in healthy volunteers. We observed no significant differences between the groups before treatment in WBC-count, D-dimer, CRP, Ferritin or LDH levels. We found that Ferritin and LDH levels significantly raised after the 7th day follow-up only in the Control group (p<0.0001 and p=0.0005, respectively), while mean values of the same indicators did not change in patients in the Treatment group after the radionuclide treatment. D-dimer values also lowered in the radionuclide treated group, however, this effect was not statistically significant. Furthermore, we evaluated a significant decrease in CD19+ cell counts in patients of the radionuclide-treated group. CONCLUSION Inhaled low-dose radionuclide therapy of 99mTc aerosol affects the major prognostic indicators of COVID-19-related pneumonia restraining inflammatory response. Overall, we identified no evidence of major adverse events in the group receiving radionuclide.
Collapse
Affiliation(s)
- Peter Shegay
- Medical Radiological Research Center Department of Regenerative Medicine Obninsk Russian Federation
| | - Alexey Leontyev
- P.A. Hertzen Moscow Oncology Research Institute Radionuclide Diagnostics Department Moscow Russian Federation
| | - Denis Baranovskii
- Medical Radiological Research Center Department of Regenerative Medicine Obninsk Russian Federation
| | - German Davydov
- P.A. Hertzen Moscow Oncology Research Institute Radionuclide Diagnostics Department Moscow Russian Federation
| | - Marina Poluektova
- P.A. Hertzen Moscow Oncology Research Institute Radionuclide Diagnostics Department Moscow Russian Federation
| | - Lyudmila Grivtsova
- Medical Radiological Research Center Laboratory Diagnostics Department Obninsk Russian Federation
| | - Vasily Petriev
- Medical Radiological Research Center Radionuclide Diagnostics Department Obninsk Russian Federation
| | - Valeriy Stepanenko
- Medical Radiological Research Center Radionuclide Diagnostics Department Obninsk Russian Federation
| | - Igor Gulidov
- Medical Radiological Research Center Radionuclide Diagnostics Department Obninsk Russian Federation
| | - Valeriy Krylov
- Medical Radiological Research Center Radionuclide Diagnostics Department Obninsk Russian Federation
| | - Svetlana Osadchaya
- Medical Radiological Research Center Radionuclide Diagnostics Department Obninsk Russian Federation
| | - Vladimir Petrov
- Medical Radiological Research Center Radionuclide Diagnostics Department Obninsk Russian Federation
| | - Maria Sedova
- Medical Radiological Research Center Radionuclide Diagnostics Department Obninsk Russian Federation
| | - Mikhail Vekilyan
- P.A. Hertzen Moscow Oncology Research Institute Radionuclide Diagnostics Department Moscow Russian Federation
| | - Olga Krasilnikova
- P.A. Hertzen Moscow Oncology Research Institute Department of Regenerative Medicine Moscow Russian Federation
| | - Sergey Morozov
- Scientific Research Institute of Healthcare Organization and Medical Management Research and Practical Center of Medical Radiology Moscow Russian Federation
| | - Sergey Ivanov
- Medical Radiological Research Center Department of Regenerative Medicine Obninsk Russian Federation
| | - Ilya Klabukov
- Medical Radiological Research Center Department of Regenerative Medicine Obninsk Russian Federation
| | - Andrey Kaprin
- Medical Radiological Research Center Department of Regenerative Medicine Obninsk Russian Federation
| |
Collapse
|
12
|
Ibragimov B, Arzamasov K, Maksudov B, Kiselev S, Mongolin A, Mustafaev T, Ibragimova D, Evteeva K, Andreychenko A, Morozov S. A 178-clinical-center experiment of integrating AI solutions for lung pathology diagnosis. Sci Rep 2023; 13:1135. [PMID: 36670118 PMCID: PMC9859802 DOI: 10.1038/s41598-023-27397-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Accepted: 01/02/2023] [Indexed: 01/22/2023] Open
Abstract
In 2020, an experiment testing AI solutions for lung X-ray analysis on a multi-hospital network was conducted. The multi-hospital network linked 178 Moscow state healthcare centers, where all chest X-rays from the network were redirected to a research facility, analyzed with AI, and returned to the centers. The experiment was formulated as a public competition with monetary awards for participating industrial and research teams. The task was to perform the binary detection of abnormalities from chest X-rays. For the objective real-life evaluation, no training X-rays were provided to the participants. This paper presents one of the top-performing AI frameworks from this experiment. First, the framework used two EfficientNets, histograms of gradients, Haar feature ensembles, and local binary patterns to recognize whether an input image represents an acceptable lung X-ray sample, meaning the X-ray is not grayscale inverted, is a frontal chest X-ray, and completely captures both lung fields. Second, the framework extracted the region with lung fields and then passed them to a multi-head DenseNet, where the heads recognized the patient's gender, age and the potential presence of abnormalities, and generated the heatmap with the abnormality regions highlighted. During one month of the experiment from 11.23.2020 to 12.25.2020, 17,888 cases have been analyzed by the framework with 11,902 cases having radiological reports with the reference diagnoses that were unequivocally parsed by the experiment organizers. The performance measured in terms of the area under receiving operator curve (AUC) was 0.77. The AUC for individual diseases ranged from 0.55 for herniation to 0.90 for pneumothorax.
Collapse
Affiliation(s)
- Bulat Ibragimov
- Department of Computer Science, University of Copenhagen, Copenhagen, Denmark.
| | - Kirill Arzamasov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia
| | - Bulat Maksudov
- School of Electronic Engineering, Dublin City University, Dublin, Ireland
| | | | - Alexander Mongolin
- Innopolis University, Innopolis, Russia
- Nova Information Management School, Universidade Nova de Lisboa, Lisbon, Portugal
| | - Tamerlan Mustafaev
- Innopolis University, Innopolis, Russia
- University Clinic Kazan State University, Kazan, Russia
| | | | - Ksenia Evteeva
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia
| | - Anna Andreychenko
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia
| | - Sergey Morozov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia
- Osimis SA, Liege, Belgium
| |
Collapse
|
13
|
Zakharov A, Pisov M, Bukharaev A, Petraikin A, Morozov S, Gombolevskiy V, Belyaev M. Interpretable vertebral fracture quantification via anchor-free landmarks localization. Med Image Anal 2023; 83:102646. [PMID: 36279768 DOI: 10.1016/j.media.2022.102646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 07/20/2022] [Accepted: 09/27/2022] [Indexed: 12/12/2022]
Abstract
Vertebral body compression fractures are early signs of osteoporosis. Though these fractures are visible on Computed Tomography (CT) images, they are frequently missed by radiologists in clinical settings. Prior research on automatic methods of vertebral fracture classification proves its reliable quality; however, existing methods provide hard-to-interpret outputs and sometimes fail to process cases with severe abnormalities such as highly pathological vertebrae or scoliosis. We propose a new two-step algorithm to localize the vertebral column in 3D CT images and then detect individual vertebrae and quantify fractures in 2D simultaneously. We train neural networks for both steps using a simple 6-keypoints based annotation scheme, which corresponds precisely to the current clinical recommendation. Our algorithm has no exclusion criteria, processes 3D CT in 2 seconds on a single GPU, and provides an interpretable and verifiable output. The method approaches expert-level performance and demonstrates state-of-the-art results in vertebrae 3D localization (the average error is 1mm), vertebrae 2D detection (precision and recall are 0.99), and fracture identification (ROC AUC at the patient level is up to 0.96). Our anchor-free vertebra detection network shows excellent generalizability on a new domain by achieving ROC AUC 0.95, sensitivity 0.85, specificity 0.9 on a challenging VerSe dataset with many unseen vertebra types.
Collapse
Affiliation(s)
- Alexey Zakharov
- IRA Labs Ltd, Moscow, Russia; Skolkovo Institute of Science and Technology, Moscow, Russia
| | - Maxim Pisov
- IRA Labs Ltd, Moscow, Russia; Skolkovo Institute of Science and Technology, Moscow, Russia; Kharkevich Institute for Information Transmission Problems, Moscow, Russia
| | | | - Alexey Petraikin
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Russia
| | | | | | - Mikhail Belyaev
- IRA Labs Ltd, Moscow, Russia; Skolkovo Institute of Science and Technology, Moscow, Russia.
| |
Collapse
|
14
|
Bordin D, Morozov S, Plavnik R, Bakulina N, Voynovan I, Skibo I, Isakov V, Bakulin I, Andreev D, Maev I. Helicobacter pylori infection prevalence in ambulatory settings in 2017-2019 in RUSSIA: The data of real-world national multicenter trial. Helicobacter 2022; 27:e12924. [PMID: 35971900 DOI: 10.1111/hel.12924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Revised: 07/07/2022] [Accepted: 07/29/2022] [Indexed: 12/09/2022]
Abstract
BACKGROUND The recent data on the prevalence of Helicobacter pylori (H. pylori) infection in Russia are limited. The aim of the study was to compare Helicobacter pylori infection prevalence in ambulatory settings in Russia in 2017 and 2019 years. MATERIALS AND METHODS Subjects visiting primary care centers were invited to take part in the study. H. pylori status was assessed by 13 C-urea breath test (UBT). Data on subjects' demography, previous treatment exposure, and place of residence were collected in all federal districts of Russia in 2017 and in 2019 calendar years and processed centrally. RESULTS The data of 19,875 subjects were available for analysis. The prevalence of H. pylori infection assessed by positive UBT in treatment-naive subjects was highest in the Southern (54.9%) and the North Caucasian (45.1%) federal districts. A significant difference (p < 0.05) in H. pylori prevalence between two testing periods was found only in a half of federal districts: the Central (46.2% in 2017 vs. 36.2% in 2019), the Northwestern (38.6% vs. 35.5% accordingly), the Volga (40.6% vs. 33.0%, accordingly), and the Ural (40.4% vs. 32.7%, accordingly). The lowest prevalence of H. pylori infection was revealed in the age group <18 years old (20.2%), while the highest in the age group of 41-50 years old (43.9%). In 2017, the prevalence of H. pylori was significantly (p < 0.05) higher than in 2019 in all age groups but younger than 18 and older than 70 y.o., where similar rates were found during both study periods. CONCLUSIONS The prevalence of H. pylori according to 13 C-UBT testing of primary care visitors in Russia is lower than expected (38.8%). The highest prevalence of H. pylori infection found in the Southern and the North Caucasian federal districts of Russia and in the age group of 41-50 years old. This study was registered at clinicaltrials.gov (NCT04892238).
Collapse
Affiliation(s)
- Dmitry Bordin
- A. S. Loginov Moscow Clinical Scientific Center, Moscow, Russia.,Tver State Medical University, Tver, Russia.,A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - Sergey Morozov
- Federal Research Center of Nutrition and Biotechnology, Moscow, Russia
| | | | - Natalia Bakulina
- I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russia
| | - Irina Voynovan
- A. S. Loginov Moscow Clinical Scientific Center, Moscow, Russia
| | | | - Vasily Isakov
- Federal Research Center of Nutrition and Biotechnology, Moscow, Russia
| | - Igor Bakulin
- I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russia
| | - Dmitrii Andreev
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - Igor Maev
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
15
|
Morozov S, Sentsova T. Local inflammatory response to gastroesophageal reflux: Association of gene expression of inflammatory cytokines with esophageal multichannel intraluminal impedance-pH data. World J Clin Cases 2022; 10:9254-9263. [PMID: 36159432 PMCID: PMC9477692 DOI: 10.12998/wjcc.v10.i26.9254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Revised: 04/21/2022] [Accepted: 08/16/2022] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Gene expression of inflammatory cytokines may take part in the pathophysiology of different forms of gastroesophageal reflux disease (GERD).
AIM To explore gene expression of inflammatory cytokines in esophageal mucosa in patients with erosive esophagitis (EE) and non-erosive forms of GERD (NERD) and its association with data of esophageal multichannel intraluminal impedance-pH (MII-pH) measurements.
METHODS This was a single-center prospective study. Esophageal mucosa samples were taken from the lower part of the esophagus during endoscopy. Expression of interleukin (IL)-1β, IL-10, IL-18, tumor necrosis factor α (TNFA), toll-like receptor 4 (TLR4), GATA binding protein 3 (GATA3), differentiation cluster 68 (CD68) and β-2 microglobulin genes in esophageal mucosa was assessed with ImmunoQuantex assays. MII-pH measurements were performed on all the participants. Diagnosis of GERD was confirmed by the results of the MII-pH data. Based on the endoscopy, patients were allocated to the groups of EE and NERD. The control group consisted of non-symptomatic subjects with normal endoscopy and MII-pH results. We used nonparametric statistics to compare the differences between the groups. Association of expression of the mentioned genes with the results of the MII-pH data was assessed with Spearman’s rank method.
RESULTS Data from 60 patients with GERD and 10 subjects of the control group were available for the analysis. Higher expression of IL-18 (5.89 ± 0.4 vs 5.28 ± 1.1, P = 0.04) and GATA3 (2.92 ± 0.86 vs 2.23 ± 0.96, P = 0.03) was found in the EE group compared to NERD. Expression of IL-1β, IL-18, TNFA, and TLR4 was lower (P < 0.05) in the control group compared to EE and NERD. Esophageal acid exposure correlated with the expression of IL-1β (Spearman’s rank r = 0.29), IL-18 (r = 0.31), TNFA (r = 0.35), GATA3 (r = 0.34), TLR4 (r = 0.29), and CD68 (r = 0.37). Mean esophageal рН correlated inversely with the expression of IL-18, TNFA, GATA3, TLR4, and CD68. No association of gene expression with the number of gastroesophageal refluxes was found.
CONCLUSION In patients with EE, local expression of IL-18 and GATA3 was higher compared to subjects with NERD. Esophageal acid exposure correlated directly with expression of IL-1β, IL-18, TNFA, TLR4, CD68, and β-2 microglobulin genes. Inverse correlation was revealed between expression of IL-18, TNFA, GATA3, TLR4, and CD68 and mean esophageal pH.
Collapse
Affiliation(s)
- Sergey Morozov
- Department of Gastroenterology, Hepatology and Nutrition, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow 115446, Russia
| | - Tatyana Sentsova
- Department of Hospital Pediatrics No. 2, Russian National Research Medical University named after N.I. Pirogov, Moscow 117997, Russia
| |
Collapse
|
16
|
Batskikh S, Morozov S, Dorofeev A, Borunova Z, Kostyushev D, Brezgin S, Kostyusheva A, Chulanov V. Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer. World J Gastroenterol 2022; 28:4812-4822. [PMID: 36156926 PMCID: PMC9476854 DOI: 10.3748/wjg.v28.i33.4812] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Revised: 06/15/2022] [Accepted: 08/16/2022] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND The etiology of pancreatic cancer remains unclear. This limits the possibility of prevention and effective treatment. Hepatitis B virus (HBV) is responsible for the development of different types of cancer, but its role in pancreatic cancer is still being discussed.
AIM To assess the prevalence of previous HBV infection and to identify viral biomarkers in patients with pancreatic ductal adenocarcinoma (PDAC) to support the role of the virus in etiology of this cancer.
METHODS The data of 130 hepatitis B surface antigen-negative subjects were available for the final analysis, including 60 patients with PDAC confirmed by cytology or histology and 70 sex- and age-matched controls. All the participants were tested for HBV biomarkers in blood [antibody to hepatitis B core antigen (anti-HBc), antibody to hepatitis B surface antigen (anti-HBs) and HBV DNA], and for those with PDAC, biomarkers in resected pancreatic tissues were tested (HBV DNA, HBV pregenomic RNA and covalently closed circular DNA). We performed immunohistochemistry staining of pancreatic tissues for hepatitis B virus X antigen and Ki-67 protein. Non-parametric statistics were used for the analysis.
RESULTS Anti-HBc was detected in 18/60 (30%) patients with PDAC and in 9/70 (13%) participants in the control group (P = 0.029). Accordingly, the odds of PDAC in anti-HBc-positive subjects were higher compared to those with no previous HBV infection (odds ratio: 2.905, 95% confidence interval: 1.191-7.084, standard error 0.455). HBV DNA was detected in 8 cases of PDAC and in 6 of them in the pancreatic tumor tissue samples only (all patients were anti-HBc positive). Blood HBV DNA was negative in all subjects of the control group with positive results of the serum anti-HBc test. Among 9 patients with PDAC, 5 revealed signs of replicative competence of the virus (covalently closed circular DNA with or without pregenomic RNA) in the pancreatic tumor tissue samples. Hepatitis B virus X antigen expression and active cell proliferation was revealed by immunohistochemistry in 4 patients with PDAC in the pancreatic tumor tissue samples.
CONCLUSION We found significantly higher risks of PDAC in anti-HBc-positive patients. Detection of viral replication and hepatitis B virus X protein expression in the tumor tissue prove involvement of HBV infection in pancreatic cancer development.
Collapse
Affiliation(s)
- Sergey Batskikh
- Department of Hepatology, Moscow Clinical Scientific Center N.A. A.S. Loginov, Moscow 111123, Russia
| | - Sergey Morozov
- Department of Gastroenterology, Hepatology and Nutrition, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow 115446, Russia
| | - Alexey Dorofeev
- Department of Scientific and Clinical Laboratory Research, Moscow Clinical Scientific Center N.A. A.S. Loginov, Moscow 111123, Russia
| | - Zanna Borunova
- Department of Scientific and Clinical Laboratory Research, Moscow Clinical Scientific Center N.A. A.S. Loginov, Moscow 111123, Russia
| | - Dmitry Kostyushev
- Laboratory of Genetic Technologies, Sechenov University, Moscow 119435, Russia
- Division of Biotechnology, Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, Sochi 354340, Russia
| | - Sergey Brezgin
- Laboratory of Genetic Technologies, Sechenov University, Moscow 119435, Russia
- Division of Biotechnology, Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, Sochi 354340, Russia
| | | | - Vladimir Chulanov
- Laboratory of Genetic Technologies, Sechenov University, Moscow 119435, Russia
- Division of Biotechnology, Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, Sochi 354340, Russia
- Laboratory of Genetic Technologies and Translational Research, National Medical Research Center for Tuberculosis and Infectious Diseases of Ministry of Health of Russia, Moscow 127994, Russia
| |
Collapse
|
17
|
Batskikh S, Morozov S, Kostyushev D. Hepatitis B virus markers in hepatitis B surface antigen negative patients with pancreatic cancer: Two case reports. World J Hepatol 2022; 14:1512-1519. [PMID: 36158906 PMCID: PMC9376784 DOI: 10.4254/wjh.v14.i7.1512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 05/25/2022] [Accepted: 06/27/2022] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Hepatitis B virus (HBV) is a known carcinogen that may be involved in pancreatic cancer development. Detection of HBV biomarkers [especially expression of HBV regulatory X protein (HBx)] within the tumor tissue may provide direct support for this. However, there is still a lack of such reports, particularly in non-endemic regions for HBV infection. Here we present two cases of patients with pancreatic ductal adenocarcinoma, without a history of viral hepatitis, in whom the markers of HBV infection were detected in blood and in the resected pancreatic tissue.
CASE SUMMARY The results of examination of two patients with pancreatic cancer, who gave informed consent for participation and publication, were the source for this study. Besides standards of care, special examination to reveal occult HBV infection was performed. This included blood tests for HBsAg, anti-HBc, anti-HBs, HBV DNA, and pancreatic tissue examinations with polymerase chain reaction for HBV DNA, pregenomic HBV RNA (pgRNA HBV), and covalently closed circular DNA HBV (cccDNA) and immunohistochemistry staining for HBxAg and Ki-67. Both subjects were operated on due to pancreatic ductal adenocarcinoma and serum HBsAg was not detected. However, in both of them anti-HBc antibodies were detected in blood, although HBV DNA was not found. Examination of the resected pancreatic tissue gave positive results for HBV DNA, expression of HBx, and active cellular proliferation by Ki-67 index in both cases. However, HBV pgRNA and cccDNA were detected only in case 1.
CONCLUSION These cases may reflect potential involvement of HBV infection in the development of pancreatic cancer.
Collapse
Affiliation(s)
- Sergey Batskikh
- Department of Hepatology, Moscow Clinical Research Center named after A.S. Loginov, Moscow 111123, Russia
| | - Sergey Morozov
- Department of Gastroenterology, Hepatology and Nutrition, Federal Research Center of Nutrition and Biotechnology, Moscow 115446, Russia
| | - Dmitry Kostyushev
- Laboratory of Genetic Technologies, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), Moscow 119991, Russia
- Division of Biotechnology, Sirius University of Science and Technology, Sochi 354340, Russia
| |
Collapse
|
18
|
Morozov S, Vorobyova I, Vorobyova V, Isakov V, Kochetkova A, Sasunova A. New Specialized Food Product. Curr Dev Nutr 2022. [PMCID: PMC9193741 DOI: 10.1093/cdn/nzac053.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objectives
Aim of the study was to assess efficacy of new specialized food product “SPP2” in patients with non-alcoholic steatohepatitis (NASH).
Methods
New specialized food product (SPP2) was developed based on literature data on the efficacy of biologically active compounds in pathogenesis of NASH. It contains: protein, fat, ω-3 PUFAs, carbohydrates, soluble fibre, coenzime Q10, L-carnitine, α-lipoic acid, vitamins (A, B1, B2, B6, PP, B12, D3, C, K), phospholipids. Patients with NASH (per EASL guidelines), were invited to participate in the study and were randomized either to receive iso-caloric diet (based on the data of indirect caloriemetry) alone (ICD) or iso-caloric diet and SPP2 (SPP2). Repeated examinations of body composition with bioimpedance and blood tests were performed at baseline (BL) and after 14 days (EOT) of treatment. The patients were advised to follow usual physical activity during the study. Non-parametric statistics was used to compare BL and EOT characteristics in the groups.
Results
The data of examination of 25 subjects were available. The ICD (n = 8) and SPP2 (n = 17) groups did not differ by demographic and baseline characteristics. The use of SPP2 allowed to achieve better control of weight in SPP2 group (mean ± SD): 117.5 ± 30.1 kg/m2 at BL vs 114.9 ± 28.8 kg/m2 at EOT, P < 0.01) than in ICD (106.7 ± 22.1 at BL vs 104.0 ± 16.8 kg/m2 at EOT, P = 0.07). In SPP2 group significant decrease of cholesterol (5.3 ± 1.3 mmol/L at BL vs 4.6 ± 1.3 mmol/L, P = 0.003), low density lipoproteids (3.7 ± 1.0 mmol/L at BL vs 3.3 ± 1.0 at EOT, P = 0.009), and HOMA-IR (6.1 ± 3.2 vs 3.2 ± 1.5, P = 0.04) was achieved, while in ICD these parameters remained unchanged. While ALT and AST decreased in both groups, significant decrease in alkaline phosphatase and gamma-GT was found only in SPP2 group.
Conclusions
New specialized food product “SPP2” in combination with iso-caloric diet lead to greater decrease of weight, than iso-caloric diet alone. It helps to achieve faster improvement of blood lipid profile and insulin resistance.
Funding Sources
Ministry of Science and Higher Education of Russia, research grant FGMF-2022–0005.
Collapse
Affiliation(s)
| | | | | | - Vasily Isakov
- Federal Research Center of Nutrition and Biotechnology
| | | | | |
Collapse
|
19
|
Pilipenko V, Morozov S, Isakov V. Efficacy of Newly Developed Kombucha-Based Specialized Food Product for Treatment of Constipation-Predominant Irritable Bowel Syndrome. Curr Dev Nutr 2022. [PMCID: PMC9194178 DOI: 10.1093/cdn/nzac077.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
Objectives Aim: to assess the efficacy of kombucha-based specialized food product, enriched with inulin in patients with constipation-predominant irritable bowel syndrome. Methods The study (NCT05164861) was approved by LEC and enrolled subjects with constipation-predominant irritable bowel syndrome (according to ROME IV). The subjects were randomized to receive either 220 ml of a non-alcoholic drink, based on pasteurized kombucha (KG), enriched with inulin (1.15 g/100ml) or 220 ml water (control group, CG), for 10 days. Except study product, subjects were advised to follow their usual diet. Standard examination included evaluation of stool frequency (bowel movements per day), stool form (with the Bristol stool scale) and evaluation of concomitant symptoms (abdominal pain/discomfort, abdominal fullness, bloating, and feeling of incomplete bowel emptying) with the use of 5-point Likert scale before (BL) and 10 days after the start of intervention (EOT). Results The complete data of 40 subjects were available for the analysis. Significant increase of stool frequency was found at the EOT compared to BL in KG (n = 20), Mean ± SD: 0.60 ± 0.31 to 0.85 ± 0.19 times/day; p = 0.004, while there was no change in CG (n = 20): 0.63 ± 0.33 vs 0.72 ± 0.28, p > 0.05. Mean values of stool scale form increased in KG (2.95 ± 1.15 to 4.4 ± 0.97; p = 0.001), while remained unchanged in CG (2.94 ± 1.2 vs 3.4 ± 1.2, p = 0.6). Mean values of the Bristol stool scale in KG and CG differed significantly at EOT (p = 0.018). Significant decrease in mean values of incomplete bowel emptying feeling was found in KG (1.88 ± 0.78 at BL vs 1.41 ± 0.56 points at EOT, p = 0.015), but not in the control group. There was no difference in patient's reports for other symptoms between KG and CG. Conclusions New specialized kombucha-based drink enriched with inulin is well-tolerated and increases stool frequency and consistency in patients with constipation-predominant irritable bowel syndrome. Funding Sources Russian Science Foundation (research grant # 19-76-30,014).
Collapse
Affiliation(s)
| | - Sergey Morozov
- Federal Research Centre of Nutrition, Biotechnology and Food Safety
| | | |
Collapse
|
20
|
Pilipenko V, Morozov S, Isakov V. New Specialized Kombucha-Based Non-alcoholic Pasteurized Beverage Shows Favorable Profile of Short-Term Safety and Tolerability in Patients With Constipation. Curr Dev Nutr 2022. [PMCID: PMC9194009 DOI: 10.1093/cdn/nzac077.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Objectives Kombucha is a globally known beverage, perceived as “healthy”. It may be a basis for the development of new specialized beverages to increase dietary fiber consumption. However, safety and tolerability of the kombucha-based beverages is poorly studied yet. Aim: to assess short-term safety and tolerability of new kombucha-based pasteurized specialized non-alcoholic beverage, enriched with inulin. Methods This study (NCT05164861) enrolled subjects with constipation-predominant irritable bowel syndrome (per ROME IV). The subjects were randomized to receive either 220 ml of the non-alcoholic kombucha-based pasteurized beverage (KG), enriched with inulin (1.15 g/100ml) or 220 ml water (control group, CG), for 10 days. Except study product, subjects were advised to follow their usual diet. Organoleptic evaluation of the beverage; assessment of symptoms (abdominal pain/discomfort, abdominal fullness, bloating, heartburn) with the use of 5-point Likert scale; blood chemistry and hematology were performed before (BL) and on the 10th day of study (EOT). Patients were asked to report any adverse events during the study period. Results There were 20 subjects in KG and 20 in CG groups. New specialized food product was well-tolerated, no SAE occurred during the study. No exacerbation of the pre-existing symptoms was observed in KG, including abdominal pain/discomfort (1.28 ± 0.56 vs 1.25 ± 0.56; p > 0.05), abdominal fullness (1.53 ± 0.69 vs 1.22 ± 0.47; p > 0.05), bloating (1.60 ± 0.64 vs 1.37 ± 0.60; p > 0.05), and heartburn (1.28 ± 0.62 vs 1.25 ± 0.52; p > 0.05) during the study. The rate of AEs was low (5%) and did not differ compared to CG. Mean integrative score of organoleptic evaluation of the beverage was good (91.0 ± 13.7%) with non-significant increase at EOT (94.2 ± 6.5%). No laboratory AE were observed. Conclusions This study suggest that new specialized kombucha-based drink enriched with inulin is well-tolerated, and has favorable safety profile. Funding Sources Russian Science Foundation (research grant # 19-76-30,014).
Collapse
Affiliation(s)
| | - Sergey Morozov
- Federal Research Centre of Nutrition, Biotechnology and Food Safety
| | | |
Collapse
|
21
|
Morozov S, Sasunova A, Isakov V. Clinical Safety and Tolerability of New Specialized Food Product. Curr Dev Nutr 2022. [PMCID: PMC9193352 DOI: 10.1093/cdn/nzac053.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Objectives The use of specialized food products may increase efficacy of treatment in patients with non-alcoholic steatohepatitis (NASH). The aim of the study was to assess clinical safety and tolerability of newly developed specialized food product “SPP2” in patients with non-alcoholic steatohepatitis. Methods New specialized food product (SPP2) was developed based on literature data on the efficacy of active biological compounds on pathogenesis of NASH. It contains: protein, fat, ω-3 PUFAs, carbohydrates, soluble fibre, Coenzime Q10, L-carnitine, α-lipoic acid, vitamins (A, B1, B2, B6, PP, B12, D3, C, K), phospholipids. The test batch of the product passed laboratory control for biological and toxicological safety. The study was approved by LEC and registered (NCT04308980). Patients with NASH (per EASL), were invited to participate and were randomized to receive iso-caloric diet alone (ICD) or iso-caloric diet and SPP2 (SPP2). Energy value of the diet was amended by calorie content of SPP2. The patients were advised to follow usual physical activity and report any adverse events (AE) occurred during the study. Organoleptic assessment with the use of 5-point Likert scale and repeated blood tests on chemistry and hematology were performed at baseline (BL) and after 14 days (EOT) of treatment. Non-parametric statistics was used for the analysis Results One subject was lost to follow-up in ICD group and one postponed the use of SPP2 due to the not related to safety reasons. The data of 25 subjects were available for the final analysis. The ICD (n = 8) and SPP2 (n = 17) groups did not differ by demographic and baseline characteristics. Adherence to diet was 88% in ICD and 92% in SPP2 groups, p = 0.7. Compliance with SPP was 97%. No serious adverse events occurred during the study. Organoleptic assessment of SPP2 initially: appearance (Mean ± SD) 3.9 ± 0.83 points; color 4.0 ± 0.5; aroma 3.6 ± 0.9; texture 3.7 ± 0.8; taste 3.9 ± 0.7; resulting in a mean score 3.9 ± 0.4 point at BL. No dissatisfaction revealed at EOT: the mean organoleptic score was 4.2 ± 0.7 points (P = 0.07). No laboratory AEs occurred. Conclusions New specialized food product “SPP2” in combination with iso-calorie diet is safe and well-tolerated by patients with NASH. Funding Sources Ministry of Science and Higher Education of Russia, FGMF-2022–0005.
Collapse
Affiliation(s)
| | | | - Vasily Isakov
- Federal Research Center of Nutrition and Biotechnology
| |
Collapse
|
22
|
Zinchenko V, Chetverikov S, Akhmad E, Arzamasov K, Vladzymyrskyy A, Andreychenko A, Morozov S. Changes in software as a medical device based on artificial intelligence technologies. Int J Comput Assist Radiol Surg 2022; 17:1969-1977. [PMID: 35691995 PMCID: PMC9188918 DOI: 10.1007/s11548-022-02669-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Accepted: 04/30/2022] [Indexed: 11/28/2022]
Abstract
Purpose to develop a procedure for registering changes, notifying users about changes made, unifying software as a medical device based on artificial intelligence technologies (SaMD-AI) changes, as well as requirements for testing and inspections—quality control before and after making changes. Methods The main types of changes, divided into two groups—major and minor. Major changes imply a subsequent change of a SaMD-AI version to improve efficiency and safety, to change the functionality, and to ensure the processing of new data types. Minor changes imply those that SaMD-AI developers can make due to errors in the program code. Three types of SaMD-AI testings are proposed to use: functional testing, calibration testing or control, and technical testing. Results The presented approaches for validation SaMD-AI changes were introduced. The unified requirements for the request for changes and forms of their submission made this procedure understandable for SaMD-AI developers, and also adjusted the workload for the Experiment experts who checked all the changes made to SaMD-AI. Conclusion This article discusses the need to control changes in the module of SaMD-AI, as innovative products influencing medical decision making. It justifies the need to control a module operation of SaMD-AI after making changes. To streamline and optimize the necessary and sufficient control procedures, a systematization of possible changes in SaMD-AI and testing methods was carried out.
Collapse
Affiliation(s)
- Victoria Zinchenko
- The Department of Innovative Technologies, State Budget-Funded Health Care Institution of the City of Moscow "Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department", 24 Petrovka Str., Bldg. 1, 127051, Moscow, Russia
| | - Sergey Chetverikov
- The Department of Medical Informatics, Radiomics and Radiogenomics, State Budget-Funded Health Care Institution of the City of Moscow "Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department", 24 Petrovka Str., Bldg. 1, 127051, Moscow, Russia
| | - Ekaterina Akhmad
- The Department of Innovative Technologies, State Budget-Funded Health Care Institution of the City of Moscow "Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department", 24 Petrovka Str., Bldg. 1, 127051, Moscow, Russia.
| | - Kirill Arzamasov
- The Department of Medical Informatics, Radiomics and Radiogenomics, State Budget-Funded Health Care Institution of the City of Moscow "Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department", 24 Petrovka Str., Bldg. 1, 127051, Moscow, Russia
| | - Anton Vladzymyrskyy
- Deputy Director for Science, State Budget-Funded Health Care Institution of the City of Moscow "Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department", 24 Petrovka Str., Bldg. 1, 127051, Moscow, Russia
| | - Anna Andreychenko
- Department of Physics and Engineering, ITMO University, Kronverkskiy Prospekt, 49, 197101, Saint Petersburg, Russia.,The Department of Medical Informatics, Radiomics and Radiogenomics, State Budget-Funded Health Care Institution of the City of Moscow "Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department", 24 Petrovka Str., Bldg. 1, 127051, Moscow, Russia
| | - Sergey Morozov
- Radiology, State Budget-Funded Health Care Institution of the City of Moscow "Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department", 24 Petrovka Str., Bldg. 1, 127051, Moscow, Russia
| |
Collapse
|
23
|
Ramos-González PL, Kondo H, Morozov S, Vasilakis N, Varsani A, Cao M, Freitas-Astúa J. Editorial: The Border Between Kitavirids and Nege-Like Viruses: Tracking the Evolutionary Pace of Plant- and Arthropod-Infecting Viruses. Front Plant Sci 2022; 13:932523. [PMID: 35685019 PMCID: PMC9171497 DOI: 10.3389/fpls.2022.932523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Accepted: 05/10/2022] [Indexed: 06/15/2023]
Affiliation(s)
| | - Hideki Kondo
- Institute of Plant Science and Resources, Okayama University, Kurashiki, Japan
| | - Sergey Morozov
- A. N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia
| | - Nikolaos Vasilakis
- Institute for Human Infections and Immunity, University of Texas Medical Branch at Galveston, Galveston, TX, United States
| | - Arvind Varsani
- Center for Fundamental and Applied Microbiomics, The Biodesign Institute, Arizona State University, Tempe, AZ, United States
| | - Mengji Cao
- Citrus Research Institute, Chinese Academy of Agricultural Sciences, Beibei, China
| | - Juliana Freitas-Astúa
- Laboratório de Fitopatologia, Embrapa Mandioca e Fruticultura, Cruz das Almas, Brazil
| |
Collapse
|
24
|
Nagaraj Y, de Jonge G, Andreychenko A, Presti G, Fink MA, Pavlov N, Quattrocchi CC, Morozov S, Veldhuis R, Oudkerk M, van Ooijen PMA. Facilitating standardized COVID-19 suspicion prediction based on computed tomography radiomics in a multi-demographic setting. Eur Radiol 2022; 32:6384-6396. [PMID: 35362751 PMCID: PMC8973680 DOI: 10.1007/s00330-022-08730-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Revised: 02/13/2022] [Accepted: 03/08/2022] [Indexed: 11/29/2022]
Abstract
Objective To develop an automatic COVID-19 Reporting and Data System (CO-RADS)–based classification in a multi-demographic setting. Methods This multi-institutional review boards–approved retrospective study included 2720 chest CT scans (mean age, 58 years [range 18–100 years]) from Italian and Russian patients. Three board-certified radiologists from three countries assessed randomly selected subcohorts from each population and provided CO-RADS–based annotations. CT radiomic features were extracted from the selected subcohorts after preprocessing steps like lung lobe segmentation and automatic noise reduction. We compared three machine learning models, logistic regression (LR), multilayer perceptron (MLP), and random forest (RF) for the automated CO-RADS classification. Model evaluation was carried out in two scenarios, first, training on a mixed multi-demographic subcohort and testing on an independent hold-out dataset. In the second scenario, training was done on a single demography and externally validated on the other demography. Results The overall inter-observer agreement for the CO-RADS scoring between the radiologists was substantial (k = 0.80). Irrespective of the type of validation test scenario, suspected COVID-19 CT scans were identified with an accuracy of 84%. SHapley Additive exPlanations (SHAP) interpretation showed that the “wavelet_(LH)_GLCM_Imc1” feature had a positive impact on COVID prediction both with and without noise reduction. The application of noise reduction improved the overall performance between the classifiers for all types. Conclusion Using an automated model based on the COVID-19 Reporting and Data System (CO-RADS), we achieved clinically acceptable performance in a multi-demographic setting. This approach can serve as a standardized tool for automated COVID-19 assessment. Keypoints • Automatic CO-RADS scoring of large-scale multi-demographic chest CTs with mean AUC of 0.93 ± 0.04. • Validation procedure resembles TRIPOD 2b and 3 categories, enhancing the quality of experimental design to test the cross-dataset domain shift between institutions aiding clinical integration. • Identification of COVID-19 pneumonia in the presence of community-acquired pneumonia and other comorbidities with an AUC of 0.92. Supplementary Information The online version contains supplementary material available at 10.1007/s00330-022-08730-6.
Collapse
Affiliation(s)
- Yeshaswini Nagaraj
- Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. .,Machine Learning Lab, DASH, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
| | - Gonda de Jonge
- Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Anna Andreychenko
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia
| | - Gabriele Presti
- Unit of Diagnostic Imaging and Interventional Radiology, Departmental Faculty of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy
| | - Matthias A Fink
- Clinic for Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.,Translational Lung Research Center Heidelberg, member of the German Center for Lung Research, Heidelberg, Germany
| | - Nikolay Pavlov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia
| | - Carlo C Quattrocchi
- Unit of Diagnostic Imaging and Interventional Radiology, Departmental Faculty of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy
| | - Sergey Morozov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia
| | - Raymond Veldhuis
- Faculty of Electrical Engineering, Mathematics Computer Science (EWI), Data management Biometrics (DMB), University of Twente, Enschede, The Netherlands
| | - Matthijs Oudkerk
- Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands.,Institute for DiagNostic Accuracy Research, Groningen, The Netherlands
| | - Peter M A van Ooijen
- Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.,Machine Learning Lab, DASH, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| |
Collapse
|
25
|
Prokkola JM, Åsheim ER, Morozov S, Bangura P, Erkinaro J, Ruokolainen A, Primmer CR, Aykanat T. Genetic coupling of life-history and aerobic performance in Atlantic salmon. Proc Biol Sci 2022; 289:20212500. [PMID: 35078367 PMCID: PMC8790367 DOI: 10.1098/rspb.2021.2500] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Accepted: 12/24/2021] [Indexed: 11/12/2022] Open
Abstract
A better understanding of the genetic and phenotypic architecture underlying life-history variation is a longstanding aim in biology. Theories suggest energy metabolism determines life-history variation by modulating resource acquisition and allocation trade-offs, but the genetic underpinnings of the relationship and its dependence on ecological conditions have rarely been demonstrated. The strong genetic determination of age-at-maturity by two unlinked genomic regions (vgll3 and six6) makes Atlantic salmon (Salmo salar) an ideal model to address these questions. Using more than 250 juveniles in common garden conditions, we quantified the covariation between metabolic phenotypes-standard and maximum metabolic rates (SMR and MMR), and aerobic scope (AS)-and the life-history genomic regions, and tested if food availability modulates the relationships. We found that the early maturation genotype in vgll3 was associated with higher MMR and consequently AS. Additionally, MMR exhibited physiological epistasis; it was decreased when late maturation genotypes co-occurred in both genomic regions. Contrary to our expectation, the life-history genotypes had no effects on SMR. Furthermore, food availability had no effect on the genetic covariation, suggesting a lack of genotype-by-environment interactions. Our results provide insights on the key organismal processes that link energy use at the juvenile stage to age-at-maturity, indicating potential mechanisms by which metabolism and life-history can coevolve.
Collapse
Affiliation(s)
- Jenni M. Prokkola
- Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
| | - Eirik R. Åsheim
- Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
| | - Sergey Morozov
- Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
| | - Paul Bangura
- Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
| | | | - Annukka Ruokolainen
- Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
| | - Craig R. Primmer
- Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
- Institute of Biotechnology, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland
| | - Tutku Aykanat
- Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
| |
Collapse
|
26
|
Skurikhin E, Pershina O, Zhukova M, Widera D, Pan E, Pakhomova A, Krupin V, Ermakova N, Skurikhina V, Sandrikina L, Morozov S, Kubatiev A, Dygai A. Spiperone Stimulates Regeneration in Pulmonary Endothelium Damaged by Cigarette Smoke and Lipopolysaccharide. Int J Chron Obstruct Pulmon Dis 2022; 16:3575-3591. [PMID: 35002229 PMCID: PMC8722540 DOI: 10.2147/copd.s336410] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Accepted: 12/06/2021] [Indexed: 12/30/2022] Open
Abstract
Background Endothelial dysfunction and destruction of the pulmonary microcirculation are important pathogenic factors in chronic obstructive pulmonary disease (COPD). In COPD, bronchial obstruction is associated with endothelial dysfunction. Thus, new pharmacological treatment options aimed at restoring the pulmonary endothelium represent a clinical need in COPD therapy. Notch1 has been shown to protect cells against apoptosis, inflammation, and oxidative stress caused by cigarette smoke extract (CSE). Therefore, drug which effect on Notch1 may be a potential therapeutic target for COPD in the future. Methods In this study, we assessed the potential of spiperone to mediate regeneration of pulmonary endothelium in model of pulmonary emphysema induced by a CSE and lipopolysaccharide (LPS) in female C57BL/6 mice. Results Spiperone increased the number of capillaries as well as the expression of the CD31 in the alveolar tissue compared to the controls. Moreover, application of spiperone prevented alveolar wall destruction (DI), and reduced the area of emphysema. Lastly, we demonstrated that spiperone positively influenced mobilization and migration of endothelial progenitor cells (EPC, CD45−CD34+CD31+), CD309+-endothelial cells, and angiogenesis precursors (CD45−CD117+CD309+) into the lung. Spiperone administration significantly reduced the number Notch1 positive CD309+-endothelial cells and Notch1+ EPCs. Conclusion Overall, our results suggest that spiperone mediates endothelial regeneration in an animal model of COPD. Thus, it could represent a novel therapeutic approach for treatment of emphysema associated with COPD.
Collapse
Affiliation(s)
- Evgenii Skurikhin
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Olga Pershina
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Mariia Zhukova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Darius Widera
- Stem Cell Biology and Regenerative Medicine Group, School of Pharmacy, University of Reading, Whiteknights Campus, Reading, RG6 6AP, UK
| | - Edgar Pan
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Angelina Pakhomova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Vyacheslav Krupin
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Natalia Ermakova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | | | - Lubov Sandrikina
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Sergey Morozov
- Institute of General Pathology and Pathophysiology, Moscow, Russia
| | - Aslan Kubatiev
- Institute of General Pathology and Pathophysiology, Moscow, Russia
| | - Alexander Dygai
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia.,Institute of General Pathology and Pathophysiology, Moscow, Russia
| |
Collapse
|
27
|
Bykov V, Gushchina E, Morozov S, Zhuravskaya N, Kryshen K, Makarov V, Matichin A, Zueva A. Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction. Sex Med 2022; 10:100477. [PMID: 35007992 PMCID: PMC8847829 DOI: 10.1016/j.esxm.2021.100477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Revised: 11/22/2021] [Accepted: 12/01/2021] [Indexed: 12/04/2022] Open
Abstract
Background Management of diabetes mellitus-induced erectile dysfunction (DMED) is challenging because of its insufficient responses to phosphodiesterase type 5 inhibitors. Aim To compare the effects of ipidacrine, a reversible cholinesterase inhibitor, and sildenafil on DMED in a rat model of streptozotocin (STZ)-induced diabetes. Methods Erectile dysfunction (ED) caused by STZ-induced diabetes mellitus was modeled in adult male Wistar rats, which were randomized to 4 groups: untreated diabetic rats, sildenafil (5 mg/kg), ipidacrine (3.6 mg/kg) and ipidacrine (6.7 mg/kg). The test drug (ipidacrine), comparator (sildenafil) or control substance (1% starch solution) were administered orally for 5 days or 14 days. Erectile function was assessed by the change in the maximum intracavernous pressure (ICPmax) following cavernous nerve electrical stimulation. The mean arterial pressure (MAP) was recorded, and the ICPmax/MAP ratio was calculated. Sexual behavior, cholinesterase activity and blood testosterone level tests assessed. Main Outcome Measure The quantitative value of ICPmax/MAP 14 days after the start of administration of the test drug and the comparison drug. Results Animals with STZ-induced diabetes mellitus showed a significant decrease in ICPmax and ICPmax/MAP ratio compared to the intact control group. When ipidacrine was administered to rats with DMED for 14 days, an increase in these indicators was noted. It was proved that ipidacrine at a dose of 6.7 mg/kg has noninferiority compared to sildenafil on the DMED model. Significant increase in ICPmax compared to STZ-control after electrostimulation of the cavernous nerve was recorded following administration of ipidacrine at a dose of 6.7 mg/kg (P < .05) and sildenafil at a dose 5 mg/kg (P < .05). Neither the test drug, nor the comparator were associated with increase in testosterone levels in blood; as well both drugs did not promote activation of sexual behavior. Clinical Implications Ipidacrine may be considered as an effective therapy for DMED but needs to be verified in human investigations. Strengths & Limitations The role of ipidacrine, was firstly demonstrated in rats with DMED. However, the results were obtained in animal experiments, and will be further tested in the study of receptor interactions and the determination of cellular targets. Conclusion This is the first study to show that administration of ipidacrine, the reversible cholinesterase inhibitor, improved erectile function in diabetic rats and these results may be beneficial in further studies using ipidacrine for treatment of DMED, particularly in non-responders to PDE5 inhibitors. Bykov V, Gushchina E, Morozov S, et al. Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction. Sex Med 2022;10:100477.
Collapse
Affiliation(s)
- Vladimir Bykov
- N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg, Russia.
| | | | | | | | - Kirill Kryshen
- Institute of Pre-clinical Research Ltd, Leningradskaya Region, Russia
| | - Valery Makarov
- Institute of Pre-clinical Research Ltd, Leningradskaya Region, Russia
| | | | - Alena Zueva
- Institute of Pre-clinical Research Ltd, Leningradskaya Region, Russia
| |
Collapse
|
28
|
Åsheim ER, Prokkola JM, Morozov S, Aykanat T, Primmer CR. Standard metabolic rate does not associate with age-at-maturity genotype in juvenile Atlantic salmon. Ecol Evol 2022; 12:e8408. [PMID: 35127003 PMCID: PMC8794721 DOI: 10.1002/ece3.8408] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 11/02/2021] [Accepted: 11/11/2021] [Indexed: 12/11/2022] Open
Abstract
Atlantic salmon (Salmo salar) is a species with diverse life-history strategies, to which the timing of maturation contributes considerably. Recently, the genome region including the gene vgll3 has gained attention as a locus with a large effect on Atlantic salmon maturation timing, and recent studies on the vgll3 locus in salmon have indicated that its effect might be mediated through body condition and accumulation of adipose tissue. However, the cellular and physiological pathways leading from vgll3 genotype to phenotype are still unknown. Standard metabolic rate is a potentially important trait for resource acquisition and assimilation and we hypothesized that this trait, being a proxy for the maintenance energy expenditure of an individual, could be an important link in the pathway from vgll3 genotype to maturation timing phenotype. As a first step to studying links between vgll3 and the metabolic phenotype of Atlantic salmon, we measured the standard metabolic rate of 150 first-year Atlantic salmon juveniles of both sexes, originating from 14 different families with either late-maturing or early-maturing vgll3 genotypes. No significant difference in mass-adjusted standard metabolic rate was detected between individuals with different vgll3 genotypes, indicating that juvenile salmon of different vgll3 genotypes have similar maintenance energy requirements in the experimental conditions used and that the effects of vgll3 on body condition and maturation are not strongly related to maintenance energy expenditure in either sex at this life stage.
Collapse
Affiliation(s)
- Eirik R. Åsheim
- Organismal and Evolutionary Research ProgrammeUniversity of HelsinkiHelsinkiFinland
| | - Jenni M. Prokkola
- Organismal and Evolutionary Research ProgrammeUniversity of HelsinkiHelsinkiFinland
| | - Sergey Morozov
- Organismal and Evolutionary Research ProgrammeUniversity of HelsinkiHelsinkiFinland
| | - Tutku Aykanat
- Organismal and Evolutionary Research ProgrammeUniversity of HelsinkiHelsinkiFinland
| | - Craig R. Primmer
- Organismal and Evolutionary Research ProgrammeUniversity of HelsinkiHelsinkiFinland
- Institute of BiotechnologyHiLIFEUniversity of HelsinkiHelsinkiFinland
| |
Collapse
|
29
|
Morozov S, Batskikh S. Letter: hepatic steatosis in chronic hepatitis B-viral, metabolic or treatment-related? Aliment Pharmacol Ther 2022; 55:147-148. [PMID: 34907566 DOI: 10.1111/apt.16687] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/23/2021] [Accepted: 10/25/2021] [Indexed: 02/05/2023]
Affiliation(s)
- Sergey Morozov
- Gastroenterology, Hepatology and Nutrition, Federal Research Center of Nutrition and Biotechnology, Moscow, Russia
| | - Sergey Batskikh
- Moscow Clinical Research Center named after AS Loginov, Moscow, Russia
| |
Collapse
|
30
|
Batskikh S, Morozov S, Vinnitskaya E, Sbikina E, Borunova Z, Dorofeev A, Sandler Y, Saliev K, Kostyushev D, Brezgin S, Kostyusheva A, Chulanov V. May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases? Adv Ther 2022; 39:430-440. [PMID: 34762287 DOI: 10.1007/s12325-021-01983-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2021] [Accepted: 10/29/2021] [Indexed: 02/07/2023]
Abstract
INTRODUCTION Viral infections, especially with hepatotropic viruses, may trigger autoimmune liver diseases (AILDs) and deteriorate their course. However, association of previous hepatitis B virus (HBV) infection (presence of anti-HBc with or without anti-HBs or HBV DNA in serum) with AILDs is poorly studied so far. The aim of the study was to assess the prevalence of previous hepatitis B virus infection markers and its clinical significance in patients with autoimmune liver diseases. METHODS The study was based on the data obtained from 234 consecutive HBsAg-negative patients with AILDs [81 with autoimmune hepatitis (AIH), 122 with primary biliary cholangitis (PBC) and 31 with primary sclerosing cholangitis (PSC)] and 131 subjects of the control group without liver diseases. Blood samples of the enrolled patients were tested for anti-HBc and HBV DNA. Samples of liver tissue were examined by standard morphologic protocol and, in anti-HBc positive subjects, for HBV DNA. We assessed estimated risks of AILDs according to anti-HBc positivity and association of anti-HBc positivity with stage of liver fibrosis. RESULTS Anti-HBc was detected in 14.5% participants in the control group vs 26.1% (p = 0.016) in patients with AILDs (including 27.1% subjects with PBC (p = 0.021 vs control group), in 29% of PSC and 23.5% in AIH. HBV DNA was detected in three patients with PBC and in one with AIH. Positive anti-HBc test result was associated with higher risk of AILDs-odds ratio (OR) = 2.078 [95% confidence interval (CI) 1.179-3.665], especially in PBC: OR (95% CI) 2.186 (1.165-4.101). Odds of advanced stage of liver fibrosis (F3-F4 by METAVIR) in anti-HBc-positive subjects with PBC were also higher compared to those who had no previous HBV infection: OR (95% CI) 2.614 (1.153-5.926). CONCLUSIONS Significant proportions of patients with AILDs are anti-HBc positive, and some of them have OBI. Among patients with AILDs, anti-HBc-positivity is most widespread in the PBC group and in subjects with advanced stage of liver fibrosis. Our data may support the idea of an important role of previous HBV infection in the etiology and pathogenesis of AILDs (namely PBC).
Collapse
Affiliation(s)
- Sergey Batskikh
- Moscow Clinical Scientific Center n.a. A.S. Loginov, Entuziastov Shosse, 86, 111123, Moscow, Russia
| | - Sergey Morozov
- Department Gastroenterology, Hepatology and Nutrition, Federal Research Center of Nutrition and Biotechnology, Kashirskoye Shosse, 21, 115446, Moscow, Russia.
| | - Elena Vinnitskaya
- Moscow Clinical Scientific Center n.a. A.S. Loginov, Entuziastov Shosse, 86, 111123, Moscow, Russia
| | - Evgeniya Sbikina
- Moscow Clinical Scientific Center n.a. A.S. Loginov, Entuziastov Shosse, 86, 111123, Moscow, Russia
| | - Zanna Borunova
- Moscow Clinical Scientific Center n.a. A.S. Loginov, Entuziastov Shosse, 86, 111123, Moscow, Russia
| | - Alexey Dorofeev
- Moscow Clinical Scientific Center n.a. A.S. Loginov, Entuziastov Shosse, 86, 111123, Moscow, Russia
| | - Yulia Sandler
- Moscow Clinical Scientific Center n.a. A.S. Loginov, Entuziastov Shosse, 86, 111123, Moscow, Russia
| | - Kirill Saliev
- Moscow Clinical Scientific Center n.a. A.S. Loginov, Entuziastov Shosse, 86, 111123, Moscow, Russia
| | - Dmitry Kostyushev
- National Medical Research Center of Tuberculosis and Infectious Diseases, Ministry of Health, 127994, Moscow, Russia
- Division of Biotechnology, Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 354340, Sochi, Russia
| | - Sergey Brezgin
- National Medical Research Center of Tuberculosis and Infectious Diseases, Ministry of Health, 127994, Moscow, Russia
- Division of Biotechnology, Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 354340, Sochi, Russia
| | - Anastasiya Kostyusheva
- National Medical Research Center of Tuberculosis and Infectious Diseases, Ministry of Health, 127994, Moscow, Russia
| | - Vladimir Chulanov
- National Medical Research Center of Tuberculosis and Infectious Diseases, Ministry of Health, 127994, Moscow, Russia
- Division of Biotechnology, Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 354340, Sochi, Russia
- Department of Infectious Diseases, Sechenov First Moscow State Medical University, 119146, Moscow, Russia
| |
Collapse
|
31
|
Skurikhin E, Pershina O, Zhukova M, Widera D, Ermakova N, Pan E, Pakhomova A, Morozov S, Kubatiev A, Dygai A. Potential of Stem Cells and CART as a Potential Polytherapy for Small Cell Lung Cancer. Front Cell Dev Biol 2021; 9:778020. [PMID: 34926461 PMCID: PMC8678572 DOI: 10.3389/fcell.2021.778020] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Accepted: 11/18/2021] [Indexed: 12/15/2022] Open
Abstract
Despite the increasing urgency of the problem of treating small cell lung cancer (SCLC), information on the causes of its development is fragmentary. There is no complete understanding of the features of antitumor immunity and the role of the microenvironment in the development of SCLC resistance. This impedes the development of new methods for the diagnosis and treatment of SCLC. Lung cancer and chronic obstructive pulmonary disease (COPD) have common pathogenetic factors. COPD is a risk factor for lung cancer including SCLC. Therefore, the search for effective approaches to prevention, diagnosis, and treatment of SCLC in patients with COPD is an urgent task. This review provides information on the etiology and pathogenesis of SCLC, analyses the effectiveness of current treatment options, and critically evaluates the potential of chimeric antigen receptor T cells therapy (CART therapy) in SCLC. Moreover, we discuss potential links between lung cancer and COPD and the role of endothelium in the development of COPD. Finally, we propose a new approach for increasing the efficacy of CART therapy in SCLC.
Collapse
Affiliation(s)
- Evgenii Skurikhin
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
- *Correspondence: Evgenii Skurikhin,
| | - Olga Pershina
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Mariia Zhukova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Darius Widera
- Stem Cell Biology and Regenerative Medicine Group, School of Pharmacy, University of Reading, Reading, United Kingdom
| | - Natalia Ermakova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Edgar Pan
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Angelina Pakhomova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
| | - Sergey Morozov
- Institute of General Pathology and Pathophysiology, Moscow, Russia
| | - Aslan Kubatiev
- Institute of General Pathology and Pathophysiology, Moscow, Russia
| | - Alexander Dygai
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia
- Institute of General Pathology and Pathophysiology, Moscow, Russia
| |
Collapse
|
32
|
Latychevskaia T, Zan R, Morozov S, Novoselov KS. Symmetry of diffraction patterns of two-dimensional crystal structures. Ultramicroscopy 2021; 228:113336. [PMID: 34174662 DOI: 10.1016/j.ultramic.2021.113336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Revised: 05/28/2021] [Accepted: 06/09/2021] [Indexed: 10/21/2022]
Abstract
Conventionally, theoretical considerations in electron microscopy employ the weak phase approximation (WPA), which is only valid for weak scattering atomic elements (C, B, N) but not for transition metal dichalcogenide (TMD) materials. This leads to many exciting phenomena being overlooked. The present theoretical study goes beyond the weak phase approximation and thus the obtained results can be applied for two-dimensional (2D) crystals made of weakly as well of strongly scattering atoms, including the TMD materials. We show that the symmetry of an electron diffraction pattern, characterized by the Friedel's pairs, is governed by the symmetry of the exit wave distribution. For an infinite periodic crystal, the exit wave is an infinite and periodic 2D distribution which can be assigned an exit wave unit cell. The latter is determined by both the chemical composition of the crystallographic unit cell and the distance between the atomic layers. For 2D crystals of identical atoms, such as graphene, the exit wave unit cell is symmetrical and, thus, a symmetrical diffraction pattern is expected. For TMD materials, the exit wave unit cell is not symmetrical and a non-symmetrical diffraction pattern is expected for both monolayer and bilayer. Conventionally asymmetry in diffraction patterns has been explained by presence of dynamical (multiple) scattering effects. Our study shows that the asymmetry of a diffraction pattern can be explained solely by the asymmetry of the exit wave unit cell. The exit wave unit cell can be asymmetrical even in kinematic (single) scattering model. Therefore, conclusions about dynamical (multiple) scattering effects in 2D materials cannot be made based solely on asymmetry of a diffraction pattern. We also show that for hexagonally arranged atoms the second-order diffraction peaks show perfectly symmetrical intensities independently on the symmetry of the exit wave unit cell distribution.
Collapse
Affiliation(s)
| | - Recep Zan
- Nanotechnology Application and Research Center, Niǧde Ömer Halisdemir University, 51240 Niǧde, Turkey
| | - Sergey Morozov
- Institute of Microelectronics Technology and High Purity Materials, Russian Academy of Sciences, Chernogolovka, Russia
| | - Kostya S Novoselov
- National Graphene Institute, University of Manchester, Oxford Road, Manchester, M13 9PL, UK; Department of Materials Science and Engineering, National University of Singapore, 117575, Singapore; Centre for Advanced 2D Materials and Graphene Research Centre, National University of Singapore, 117546, Singapore; Chongqing 2D Materials Institute, Liangjiang New Area, Chongqing, 400714, China
| |
Collapse
|
33
|
Gombolevskiy V, Gelezhe P, Morozov S, Melnikov DV, Vorontsov A, Kulberg N, Frank K, Gotkin RH, Lachman N, Cotofana S. The Course of the Angular Artery in the Midface: Implications for Surgical and Minimally Invasive Procedures. Aesthet Surg J 2021; 41:805-813. [PMID: 32593170 DOI: 10.1093/asj/sjaa176] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
BACKGROUND Previous anatomic studies have provided valuable information on the 2-dimensional course of the angular segment of the facial artery in the midface and its arterial connections. The third dimension (ie, the depth of the artery) is less well characterized. OBJECTIVES The objective of the present study was to describe the 3-dimensional pathway of the angular segment of the facial artery and its relationship to the muscles of facial expression. METHODS The bilateral location and the depth of the midfacial segment of the facial artery was measured utilizing multi-planar computed tomographic image analyses obtained from contrast agent-enhanced cranial computed tomographic scans of 156 Caucasians aged a of 45.19 ± 18.7 years and with a mean body mass index of 25.05 ± 4.9 kg/m2. RESULTS At the nasal ala, the mean depth of the main arterial trunk was 13.7 ± 3.7 mm (range, 2.7-25.0 mm), whereas at the medial canthus it was 1.02 ± 0.62 mm (range, 1.0-3.0 mm). This was reflected by the arteries' relationship to the midfacial muscles: at the nasal ala superficial to levator anguli oris in 62.0% but deep to the levator labii superioris alaeque nasi in 53.6%; at the medial canthus superficial to the levator labii superioris alaeque nasi in 83.1% and superficial to the orbicularis oculi in 82.7%. CONCLUSIONS The results presented herein confirm the high variability in the course of the angular segment of the facial artery. Various arterial pathways have been identified providing evidence that, in the midface, there is no guaranteed safe location for minimally invasive procedures.
Collapse
Affiliation(s)
- Victor Gombolevskiy
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Pavel Gelezhe
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Sergey Morozov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Dmitry V Melnikov
- Plastic Surgery Department, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | | | - Nikolay Kulberg
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Konstantin Frank
- Department for Hand, Plastic and Aesthetic Surgery, Ludwig – Maximilian University Munich, Germany
| | | | - Nirusha Lachman
- Department of Clinical Anatomy, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
| | - Sebastian Cotofana
- Department of Clinical Anatomy, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
| |
Collapse
|
34
|
Abstract
Abstract
Objectives
The aim of the study was to compare food patterns in patients with simple steatosis (SS) and non-alcoholic steatohepatitis (NASH).
Methods
Prospective study was approved by LEC and enrolled subjects with confirmed non-alcoholic fatty liver disease (SS or NASH group). Nutrilogic software (Nutrilogic, Russia) was used for diet assessment. Dietary patterns were assessed according to the Healthy Eating Index (HEI): amounts of the major groups of foods and food products (grains, fruits, vegetables, dairy products, meats, fats and confectioneries) consumption were compared to the levels described in the HEI, and individual deviation rates were obtained. Nonparametric statistics (Mann-Whitney U test) was used to compare deviation rates found in subjects of SS and NASH groups.
Results
Subjects in NASH group (n = 22) were younger (Mean ± SD: 48.6 ± 13.4 y.o.) than those in SS group (n = 156; 56.5 ± 12.3 y.o., P = 0.008). Main macronutrients consumption did not differ between the groups. Although dietary patterns of major groups of foods consumption did not differ between SS and NASH groups, analysis of the foods subgroups revealed dissimilarity in the structure of vegetables and fats consumption. Patients with NASH consumed larger amounts of potatoes (0.14 ± 0.08 vs 0.11 ± 0.15, P = 0.006), and lower – of onions (0.02 ± 0.03 vs 0.07 ± 0.1, P = 0.006); they also consumed lower amounts of dairy butter (0.14 ± 0.44 vs 0.15 ± 0.21, P = 0.009) compared to subjects with simple steatosis. No other difference in the structure of vegetables (beans, root crops, leafy and other vegetables), fats (animal fats, vegetable oils, margarines) and other major groups of foods consumption was revealed.
Conclusions
Dietary patterns of patients with non-alcoholic steatohepatitis and simple steatosis differ. The obtained results may help in diet modification in patients with NAFLD in case of confirmation in larger multicenter trials.
Funding Sources
Russian Science Foundation, grant #1976-30014.
Collapse
Affiliation(s)
| | | | - Vasily Isakov
- Federal Research Center of Nutrition and Biotechnology
| |
Collapse
|
35
|
Morozov S, Kropochev V, Isakov V. Number of Gastroesophageal Refluxes Detected With Oesophageal pH-Impedance Study Correlates With Dietary Patterns. Curr Dev Nutr 2021. [DOI: 10.1093/cdn/nzab038_045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objectives
To evaluate association of number of gastroesophageal refluxes detected with oesophageal pH-impedance study with dietary patterns
Methods
Subjects referred to oesophageal pH-impedance examination were invited to participate in the study, approved by LEC. In case of agreement, they were asked to provide data of their usual nutrition based on food frequency questionnaire (Nutrilogic, Russia). Diet was assessed in accordance with healthy eating index, for the following main groups of products: grains, fruits, vegetables, dairy products, meats, fats and confectioneries. The results are shown as a quotient of dividing the actual values by the recommended. Spearman rank R was used to analyse correlation between number of gastroesophageal refluxes (GER) detected with oesophageal pH-impedance examination and dietary patterns assessment.
Results
Data of 40 consecutive patients (12 of them with confirmed gastroesophageal reflux disease, 28 females, age (Mean ± SD): 52.2 ± 12.9 y.o.) served as the source for the study. Mean energy value of the ration was 2302 ± 1391 kcal/day. Dietary patterns for main food groups was as follows: grains 1.4 ± 0.7, vegetables 1.1 ± 0.7, fruits 0.8 ± 0.9, dairy products 0.6 ± 0.6, meats 1.7 ± 1.0, fats 0.6 ± 0.8, confectionaries 0.3 ± 0.5. Mean number of GERs was 43.8 ± 24.4, acid GERs - 26.2 ± 20.5 per day. Direct medium-strength correlation was found between pattern of dairy products consumption and total number of GERs (Spearman R = 0.47, P < 0.05), weak-acid GERs (R = 0.49, P < 0.05), non-acid GERs (R = 0.62, P < 0.05). Pattern of confectionaries consumption was associated with high (that reached proximal oesophagus, ∼17 cm above LES) GERs: R = 0.47, P < 0.05.
Conclusions
This preliminary results may serve as a basis for further research in larger comparative trials and may be considered when diet modification is planned for patients with GERD.
Funding Sources
Russian Science Foundation research grant #19–76-30014.
Collapse
Affiliation(s)
| | | | - Vasily Isakov
- Federal Research Center of Nutrition and Biotechnology
| |
Collapse
|
36
|
Morozov S, Borodina G, Strokova T. Nutrients Consumption Affect the Number of Gastroesophageal Refluxes and Oesophageal Acidity in Children. Curr Dev Nutr 2021. [DOI: 10.1093/cdn/nzab047_015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objectives
To evaluate the correlation between types and number of gastroesophageal refluxes and nutrients consumption in children and adolescents.
Methods
The study was approved by IEC. The data of examination of 219 children (7–17 y.o.), 147 with GERD and 72 controls served as a source for the study. The amount and types of GER were determined using 24-hours esophageal pH-impedansometry (Ohmega, MMS, The Netherlands). Food frequency questionnaire was used to evaluate level of nutrients consumption. To make possible comparison of data obtained in different age and sex groups of children, direct levels of nutrients consumption were converted to a percentage deviation from the recommended daily allowance rates. Spearman rank correlation analysis was performed with the use of Statistica 10 (StatSoft Inc., USA) to reveal association between usual nutrition and number of gastroesophageal reflux episodes, their acidity and duration in children.
Results
Statistically significant (p < .05) correlation of Acid exposure time was found with amounts of PUFA (Spearman R = −0.334), ω-3 (R = −0.33), ω-6 (R = −0.3); retinols (R = −0.34), niacin (R = −0.28) and ascorbic acid (R = −0.37) consumption. The number of acid refluxes correlated with energy values of the ration (R = 0.269), amount of total protein (R = 0.279), total fat (R = 0.272), total carbohydrates (R = 0.152), and added sugar (R = 0.157) consumption. The number of weak-acid refluxes was not correlated with any of the parameters of actual nutrition. We found significant correlation between the number of non-acid refluxes and amount of PUFAs (R = 0.19), ω-6 (R = 0.151), ω-3 (R = 0.19); sodium (R = 0.158), phosphorus (R = 0.166), vitamin B1 (R = 0.17), niacin (R = 0.19), and ascorbic acid (0.23).
Conclusions
We found that types and number of gastroesophageal refluxes, as well as acidification of the lower part of oesophagus may be associated with diet in children. Our results may mean that different nutrients have different impact on esophageal motility in children. The results may have practical outcome for planning non-pharmacological intervention in children with GERD
Funding Sources
Ministry of Science and Hiigher Education of Russia, research project #0529–2019-0055.
Collapse
|
37
|
Morozov S, Sasunova A, Sarkisyan V, Vorobiova V, Kochetkova A, Isakov V. New Specialized Food Product “SPP1” in Combination With Iso-Calorie Diet Shows Better Efficacy Than the Diet Alone in Treatment of Non-alcoholic Steatohepatitis. Curr Dev Nutr 2021; 5. [PMCID: PMC8181283 DOI: 10.1093/cdn/nzab047_014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Objectives The aim of the study was to assess efficacy and safety of newly developed specialized food product “SPP1” in patients with NASH. Methods New specialized food product for clinical use (SPP1) consisted of (% of the RDAs): protein 8%; fat 7% (including ω-3 PUFA 40%); soluble dietary fiber 160%; phospholipids 25%; alpha-lipoic acid 33%; betaine 10%; minerals 13%–44%; vitamins (A, E, D3, K1, C, B1, B2, B6, B12, PP, Folic acid, Pantothenic acid, Biotin) 24%–140%. The study (NCT04308980) was approved by LEC and enrolled patients with diagnosis of NASH. Subjects were randomized to the following groups: those received iso-calorie diet (according to REE, by indirect calorimetry (Quarck RMR, Italy) alone (ICD) and iso-calorie diet + SPP1 (2 portions of SPP1 a day, 14 days)(ICD + SPP1 group). Safety was assessed based on clinical and laboratory data. Repeated measurements (baseline vs those on the 15th day of the study) of body composition (InBody, South Korea), and blood chemistry were compared. Non-parametric statistics (StatSoft, USA) was used for the analysis. Results The results of complex examination of 20 subjects (12 in ICD + SPP1 and 8 in ICD group) served as a source for the study. Initially, groups did not differ by age, sex, and BMI. The product was well tolerated. In contrast to ICD group, those in ICD + SPP1 group demonstrated greater decrease of weight: BMI initially (BMI0), Mean ± SD: 38.7 ± 5.4 kg/m2 vs BMI at the end-point (BMIEOT) 37.7 ± 5.1 kg/m2, P = 0.003 in ICD + SPP1 group, whereas in the ICD group BMI0 38.9 ± 7.2 kg/m2 vs BMIEOT 37.9 ± 7.3 kg/m2, P = 0.08. These results were reached predominantly by a decrease of the weight of fat: body fat weight (BFW)0 50.2 ± 10.7 kg vs BFWEOT 48.5 ± 10.8 kg, P = 0.002 in ICD + SPP1 group, whereas BFW0 48.9 ± 11.4 kg vs BFWEOT 46.8 ± 11.6 kg, P = 0.07 in ICD group. ALT and AST levels decreased in both groups, but in neither of them was statistically significant. Conclusions The new specialized food product “SPP1” is safe, and well tolerated by patients with NASH. In combination with iso-calorie diet, it may increase efficacy of weight loss, predominantly by fat. Funding Sources Ministry of Science and Higher Education, #0529–2019-0055.
Collapse
Affiliation(s)
| | | | | | | | | | - Vasily Isakov
- Federal Research Center of Nutrition and Biotechnology
| |
Collapse
|
38
|
Gombolevskiy V, Morozov S, Chernina V, Blokhin I, Vassileva J. A phantom study to optimise the automatic tube current modulation for chest CT in COVID-19. Eur Radiol Exp 2021; 5:21. [PMID: 34046737 PMCID: PMC8159722 DOI: 10.1186/s41747-021-00218-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2020] [Accepted: 03/31/2021] [Indexed: 01/19/2023] Open
Abstract
On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) pandemic. The expert organisations recommend more cautious use of thoracic computed tomography (CT), opting for low-dose protocols. We aimed at determining a threshold value of automatic tube current modulation noise index below which there is a chance to miss an onset of ground-glass opacities (GGO) in COVID-19. A team of radiologists and medical physicists performed 25 phantom CT studies using different automatic tube current modulation settings (SUREExposure3D technology). We then conducted a retrospective evaluation of the chest CT images from 22 patients with COVID-19 and calculated the density difference between the GGO and unaffected tissue. Finally, the results were matched to the phantom study results to determine the minimum noise index threshold value. The minimum density difference at the onset of COVID-19 was 252 HU (p < 0.001). This was found to correspond to the SUREExposure 3D noise index of 36. We established the noise index threshold of 36 for the Canon scanner without iterative reconstructions, allowing for a decrease in the dose-length product by 80%. The proposed protocol needs to be validated in a prospective study.
Collapse
Affiliation(s)
- Victor Gombolevskiy
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russian Federation.
| | - Sergey Morozov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russian Federation
| | - Valeria Chernina
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russian Federation
| | - Ivan Blokhin
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russian Federation
| | - Jenia Vassileva
- Radiation Protection of Patients Unit, International Atomic Energy Agency, Vienna, Austria
| |
Collapse
|
39
|
Sosna J, Pyatigorskaya N, Krestin G, Denton E, Stanislav K, Morozov S, Kumamaru KK, Jankharia B, Mildenberger P, Forster B, Schouman-Clayes E, Bradey A, Akata D, Brkljacic B, Grassi R, Plako A, Papanagiotou H, Maksimović R, Lexa F. International survey on residency programs in radiology: similarities and differences among 17 countries. Clin Imaging 2021; 79:230-234. [PMID: 34119915 DOI: 10.1016/j.clinimag.2021.05.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2020] [Revised: 05/05/2021] [Accepted: 05/10/2021] [Indexed: 11/16/2022]
Abstract
OBJECTIVE With the initiative of the ACR International Economics Committee, a multinational survey was conducted to evaluate radiology residency programs around the world. METHODS A 31-question survey was developed. It included: economic issues, program size and length, resident's activities during daytime and call, academic aspects including syllabus and examinations. Data was tabulated using the forementioned thematic framework and was qualitatively analyzed. RESULTS Responses were received from all 17 countries that were invited to participate (France, Netherlands, Israel, UK, Russia, USA, Japan, India, Germany, Canada, Turkey, Croatia, Serbia, Italy, Ireland, Hungary, and Greece). Residency length varied between 2 and 5 years. The certificate of residency completion is provided by a local hospital [4/17 (23%)], University [6/17 (36%)], National Board [6/17 (36%)], and Ministry of Health [1/17 (6%)]. There was variability among the number of residency programs and residents per program ranging from 15 to 300 programs per nation with a 1-700 residents in each one respectively. Salaries varied significantly and ranged from 8000 to 75,000 USD equivalent. Exams are an integral part of training in all surveyed countries. Length of call varied between 5 and 26 h and the number of monthly calls ranged from 3 to 6. The future of radiology was judged as growing in [12/17 (70%)] countries and stagnant in [5/17 (30%)] countries. DISCUSSION Radiology residency programs worldwide have many similarities. The differences are in the structure of the residency programs. Stagnation and uncertainties need to be addressed to ensure the continued development of the next generation of radiologists. SUMMARY STATEMENT There are many similarities in the academic aims and approach to education and training of radiology residency programs worldwide. The differences are in the structure of the residency programs and payments to individual residents.
Collapse
Affiliation(s)
- Jacob Sosna
- Department of Radiology, Hadassah Medical Center, Hebrew University Faculty of Medicine, Jerusalem, Israel.
| | - Nadya Pyatigorskaya
- Department of Radiology Pitié-Salpêtrière, Sorbonne Universités, UPMC Univ Paris 6, Paris, France; Department of Radiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Gabriel Krestin
- Department of Radiology Pitié-Salpêtrière, Sorbonne Universités, UPMC Univ Paris 6, Paris, France
| | - Erika Denton
- Department of Radiology, Norfolk & Norwich University Hospital, UK
| | - Kim Stanislav
- Radiology Research and Practical Centre, Moscow, Russia
| | | | | | | | - Peter Mildenberger
- Department of Radiology, Universitätsmedizin Mainz Klinik und Poliklinik Radiologie, Mainz, Germany
| | - Bruce Forster
- Department of Radiology, University of British Columbia, Faculty of Medicine, Vancouver, Canada
| | | | - Adrian Bradey
- Department of Radiology, Mercy University Hospital, Cork, Ireland
| | - Deniz Akata
- Department of Radiology, Hacettepe University, Ankara, Turkey
| | - Boris Brkljacic
- Department of Radiology, Dubrava Hospital, University of Zagreb, Croatia
| | - Roberto Grassi
- Department of Radiology, Università della Campania Luigi Vanvitelli, Naples, Italy
| | - Andras Plako
- Department of Radiology, University of Szeged, Hungary
| | | | | | - Frank Lexa
- The Radiology Leadership Institute and Chair of the Commission on Leadership and Practice Development of the American College of Radiology, Reston, VA, United States of America
| |
Collapse
|
40
|
Gelezhe P, Gombolevskiy V, Morozov S, Melnikov DV, Korb TA, Aleshina OO, Frank K, Gotkin RH, Green JB, Cotofana S. Three-Dimensional Description of the Angular Artery in the Nasolabial Fold. Aesthet Surg J 2021; 41:697-704. [PMID: 32504489 DOI: 10.1093/asj/sjaa152] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Due to its arterial vasculature, the nasolabial sulcus is one of the most challenging facial regions to treat when trying to ameliorate the signs of facial aging. OBJECTIVES The aim of the present study was to provide data on the 3-dimensional course of the angular artery within the nasolabial sulcus in relation to age, gender, and body mass index to increase safety during minimally invasive treatments. METHODS Thee hundred nasolabial sulci from 75 males and 75 females of Russian Caucasian ethnic background (mean [standard deviation] age, 45.7 [18.7] years; mean body mass index, 25.14 [4.9] kg/m2) were analyzed. Bilateral multiplanar measurements were based on contrast-enhanced computed tomography cranial scans. RESULTS Up to 3 arteries could be identified within the nasolabial sulcus: ~90% contained 1 arterial trunk, ~9% had 2 trunks, and ~1% had 3 trunks; females had more arteries than men. The artery is located at mean depths of 21.6 mm at the oral commissure and 8.9 mm at the nasal ala. The angular artery was lateral to the nasolabial sulcus in 100% of cases; the smallest distance between the artery and the nasolabial sulcus was at the oral commissure (11.91 [7.9] mm) and the greatest was at the nasal ala (13.73 [3.9] mm). CONCLUSIONS In contrast to current concepts, the angular artery is not located strictly subdermal to the nasolabial sulcus but at a variable depth, and in 100% of the investigated cases lateral to the nasolabial sulcus. With increasing age, the depth and lateral distance between arteries and sulci reduces significantly, underscoring the need for special caution when injecting this site.
Collapse
Affiliation(s)
- Pavel Gelezhe
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Victor Gombolevskiy
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Sergey Morozov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Dmitry V Melnikov
- Plastic Surgery Department, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | - Tatiana Aleksandrovna Korb
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Olga Olegovna Aleshina
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
| | - Konstantin Frank
- Department for Hand, Plastic and Aesthetic Surgery, Ludwig-Maximilians University, Munich, Germany
| | | | | | - Sebastian Cotofana
- Department of Clinical Anatomy, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
| |
Collapse
|
41
|
de Munter J, Pavlov D, Gorlova A, Sicker M, Proshin A, Kalueff AV, Svistunov A, Kiselev D, Nedorubov A, Morozov S, Umriukhin A, Lesch KP, Strekalova T, Schroeter CA. Increased Oxidative Stress in the Prefrontal Cortex as a Shared Feature of Depressive- and PTSD-Like Syndromes: Effects of a Standardized Herbal Antioxidant. Front Nutr 2021; 8:661455. [PMID: 33937310 PMCID: PMC8086427 DOI: 10.3389/fnut.2021.661455] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2021] [Accepted: 03/02/2021] [Indexed: 12/30/2022] Open
Abstract
Major depression (MD) and posttraumatic stress disorder (PTSD) share common brain mechanisms and treatment strategies. Nowadays, the dramatically developing COVID-19 situation unavoidably results in stress, psychological trauma, and high incidence of MD and PTSD. Hence, the importance of the development of new treatments for these disorders cannot be overstated. Herbal medicine appears to be an effective and safe treatment with fewer side effects than classic pharmaca and that is affordable in low-income countries. Currently, oxidative stress and neuroinflammation attract increasing attention as important mechanisms of MD and PTSD. We investigated the effects of a standardized herbal cocktail (SHC), an extract of clove, bell pepper, basil, pomegranate, nettle, and other plants, that was designed as an antioxidant treatment in mouse models of MD and PTSD. In the MD model of “emotional” ultrasound stress (US), mice were subjected to ultrasound frequencies of 16–20 kHz, mimicking rodent sounds of anxiety/despair and “neutral” frequencies of 25–45 kHz, for three weeks and concomitantly treated with SHC. US-exposed mice showed elevated concentrations of oxidative stress markers malondialdehyde and protein carbonyl, increased gene and protein expression of pro-inflammatory cytokines interleukin (IL)-1β and IL-6 and other molecular changes in the prefrontal cortex as well as weight loss, helplessness, anxiety-like behavior, and neophobia that were ameliorated by the SHC treatment. In the PTSD model of the modified forced swim test (modFST), in which a 2-day swim is followed by an additional swim on day 5, mice were pretreated with SHC for 16 days. Increases in the floating behavior and oxidative stress markers malondialdehyde and protein carbonyl in the prefrontal cortex of modFST-mice were prevented by the administration of SHC. Chromatography mass spectrometry revealed bioactive constituents of SHC, including D-ribofuranose, beta-D-lactose, malic, glyceric, and citric acids that can modulate oxidative stress, immunity, and gut and microbiome functions and, thus, are likely to be active antistress elements underlying the beneficial effects of SHC. Significant correlations of malondialdehyde concentration in the prefrontal cortex with altered measures of behavioral despair and anxiety-like behavior suggest that the accumulation of oxidative stress markers are a common biological feature of MD and PTSD that can be equally effectively targeted therapeutically with antioxidant therapy, such as the SHC investigated here.
Collapse
Affiliation(s)
- Johannes de Munter
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
| | - Dmitrii Pavlov
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.,Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Anna Gorlova
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.,Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Michael Sicker
- Rehabilitation Research Unit of Clinic of Bad Kreuzbach, Bad Kreuzbach, Germany
| | - Andrey Proshin
- PK Anokhin Research Institute of Normal Physiology, Moscow, Russia
| | - Allan V Kalueff
- Ural Federal University, Yekaterinburg, Russia.,Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.,Neuroscience Program, Sirius University, Sochi, Russia.,School of Biological and Medical Physics, Moscow Institute of Physics and Technology, Moscow, Russia
| | - Andrey Svistunov
- Institute for Translational Medicine and Biotechnology, Preclinical Research Center of Sechenov First Moscow State Medical University, Moscow, Russia
| | - Daniel Kiselev
- Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia.,Institute for Translational Medicine and Biotechnology, Preclinical Research Center of Sechenov First Moscow State Medical University, Moscow, Russia.,Federal Budgetary Institute of General Pathology and Pathophysiology, Moscow, Russia
| | - Andrey Nedorubov
- Institute for Translational Medicine and Biotechnology, Preclinical Research Center of Sechenov First Moscow State Medical University, Moscow, Russia
| | - Sergey Morozov
- Federal Budgetary Institute of General Pathology and Pathophysiology, Moscow, Russia
| | - Aleksei Umriukhin
- Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Klaus-Peter Lesch
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.,Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia.,Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany
| | - Tatyana Strekalova
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.,Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia.,Federal Budgetary Institute of General Pathology and Pathophysiology, Moscow, Russia.,Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany
| | - Careen A Schroeter
- Department of Preventive Medicine, Maastricht Medical Center Annadal, Maastricht, Netherlands
| |
Collapse
|
42
|
Goncharov M, Pisov M, Shevtsov A, Shirokikh B, Kurmukov A, Blokhin I, Chernina V, Solovev A, Gombolevskiy V, Morozov S, Belyaev M. CT-Based COVID-19 triage: Deep multitask learning improves joint identification and severity quantification. Med Image Anal 2021; 71:102054. [PMID: 33932751 PMCID: PMC8015379 DOI: 10.1016/j.media.2021.102054] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Revised: 03/21/2021] [Accepted: 03/26/2021] [Indexed: 12/12/2022]
Abstract
The current COVID-19 pandemic overloads healthcare systems, including radiology departments. Though several deep learning approaches were developed to assist in CT analysis, nobody considered study triage directly as a computer science problem. We describe two basic setups: Identification of COVID-19 to prioritize studies of potentially infected patients to isolate them as early as possible; Severity quantification to highlight patients with severe COVID-19, thus direct them to a hospital or provide emergency medical care. We formalize these tasks as binary classification and estimation of affected lung percentage. Though similar problems were well-studied separately, we show that existing methods could provide reasonable quality only for one of these setups. We employ a multitask approach to consolidate both triage approaches and propose a convolutional neural network to leverage all available labels within a single model. In contrast with the related multitask approaches, we show the benefit from applying the classification layers to the most spatially detailed feature map at the upper part of U-Net instead of the less detailed latent representation at the bottom. We train our model on approximately 1500 publicly available CT studies and test it on the holdout dataset that consists of 123 chest CT studies of patients drawn from the same healthcare system, specifically 32 COVID-19 and 30 bacterial pneumonia cases, 30 cases with cancerous nodules, and 31 healthy controls. The proposed multitask model outperforms the other approaches and achieves ROC AUC scores of 0.87±0.01 vs. bacterial pneumonia, 0.93±0.01 vs. cancerous nodules, and 0.97±0.01 vs. healthy controls in Identification of COVID-19, and achieves 0.97±0.01 Spearman Correlation in Severity quantification. We have released our code and shared the annotated lesions masks for 32 CT images of patients with COVID-19 from the test dataset.
Collapse
Affiliation(s)
- Mikhail Goncharov
- Skolkovo Institute of Science and Technology, Moscow, Russia; Kharkevich Institute for Information Transmission Problems, Moscow, Russia
| | - Maxim Pisov
- Skolkovo Institute of Science and Technology, Moscow, Russia
| | - Alexey Shevtsov
- Kharkevich Institute for Information Transmission Problems, Moscow, Russia
| | - Boris Shirokikh
- Skolkovo Institute of Science and Technology, Moscow, Russia
| | - Anvar Kurmukov
- Kharkevich Institute for Information Transmission Problems, Moscow, Russia
| | - Ivan Blokhin
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Russia
| | - Valeria Chernina
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Russia
| | - Alexander Solovev
- Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russia
| | - Victor Gombolevskiy
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Russia
| | - Sergey Morozov
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Russia
| | - Mikhail Belyaev
- Skolkovo Institute of Science and Technology, Moscow, Russia.
| |
Collapse
|
43
|
Nikolis A, Frank K, Guryanov R, Gombolevskiy V, Morozov S, Makhmud K, Chernina V, Gotkin RH, Green JB, Cotofana S. Differences in Temporal Volume between Males and Females and the Influence of Age and BMI: A Cross-Sectional CT-Imaging Study. Facial Plast Surg 2021; 37:632-638. [PMID: 33684952 DOI: 10.1055/s-0041-1725201] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND The temple has been identified as one of the most compelling facial regions in which to seek aesthetic improvement-both locally and in the entire face-when injecting soft tissue fillers. OBJECTIVE The objective of this study is to identify influences of age, gender, and body mass index (BMI) on temporal parameters to better understand clinical observations and to identify optimal treatment strategies for treating temporal hollowing. METHODS The sample consisted of 28 male and 30 female individuals with a median age of 53 (34) years and a median BMI of 27.00 (6.94) kg/m2. The surface area of temporal skin, the surface area of temporal bones, and the temporal soft tissue volume were measured utilizing postprocessed computed tomography (CT) images via the Hausdorff minimal distance algorithm. Differences between the investigated participants related to age, BMI, and gender were calculated. RESULTS Median skin surface area was greater in males compared with females 5,100.5 (708) mm2 versus 4,208.5 (893) mm2 (p < 0.001) as was the median bone surface area 5,329 (690) mm2 versus 4,477 (888) mm2 (p < 0.001). Males had on average 11.04 mL greater temporal soft tissue volume compared with age and BMI-matched females with p < 0.001. Comparing the volume between premenopausal versus postmenopausal females, the median temporal soft tissue volume was 46.63 mL (11.94) versus 40.32 mL (5.69) (p = 0.014). CONCLUSION The results of this cross-sectional CT imaging study confirmed previous clinical and anatomical observations and added numerical evidence to those observations for a better clinical integration of the data.
Collapse
Affiliation(s)
- Andreas Nikolis
- Division of Plastic Surgery, McGill University Faculty of Medicine, Montreal, Quebec, Canada
| | - Konstantin Frank
- Department for Hand, Plastic and Aesthetic Surgery, Ludwig-Maximilian University, Munich, Germany
| | - Robert Guryanov
- Department of Plastic Surgery, I. M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
| | - Victor Gombolevskiy
- Moscow Health Care Department, Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies, Moscow, Russian Federation
| | - Sergey Morozov
- Moscow Health Care Department, Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies, Moscow, Russian Federation
| | - Kamal Makhmud
- Private Practice, Medlaz Clinic, Moscow, Russian Federation
| | - Valeria Chernina
- Moscow Health Care Department, Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies, Moscow, Russian Federation
| | | | - Jeremy Blair Green
- Skin Associates of South Florida, Skin Research Institute, Coral Gables, Florida
| | - Sebastian Cotofana
- Department of Clinical Anatomy, Mayo Clinic College of Medicine and Science, Rochester, Minnesota
| |
Collapse
|
44
|
Musgrave CB, Morozov S, Schinski WL, Goddard WA. Reduction of N 2 to Ammonia by Phosphate Molten Salt and Li Electrode: Proof of Concept Using Quantum Mechanics. J Phys Chem Lett 2021; 12:1696-1701. [PMID: 33560856 DOI: 10.1021/acs.jpclett.0c03467] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Electrochemical routes provide an attractive alternative to the Haber-Bosch process for cheaper and more efficient ammonia (NH3) synthesis from N2 while avoiding the onerous environmental impact of the Haber-Bosch process. We prototype a strategy based on a eutectic mixture of phosphate molten salt. Using quantum-mechanics (QM)-based reactive molecular dynamics, we demonstrate that lithium nitride (Li3N) produced from the reduction of nitrogen gas (N2) by a lithium electrode can react with the phosphate molten salt to form ammonia. We extract reaction kinetics of the various steps from QM to identify conditions with favorable reaction rates for N2 reduction by a porous lithium electrode to form Li3N followed by protonation from phosphate molten salt (Li2HPO4-LiH2PO4 mixture) to selectively form NH3.
Collapse
Affiliation(s)
- Charles B Musgrave
- Materials and Process Simulation Center, California Institute of Technology, Pasadena, California 91125, United States
| | - Sergey Morozov
- Materials and Process Simulation Center, California Institute of Technology, Pasadena, California 91125, United States
| | - William L Schinski
- Materials and Process Simulation Center, California Institute of Technology, Pasadena, California 91125, United States
| | - William A Goddard
- Materials and Process Simulation Center, California Institute of Technology, Pasadena, California 91125, United States
| |
Collapse
|
45
|
Shirokikh B, Shevtsov A, Dalechina A, Krivov E, Kostjuchenko V, Golanov A, Gombolevskiy V, Morozov S, Belyaev M. Accelerating 3D Medical Image Segmentation by Adaptive Small-Scale Target Localization. J Imaging 2021; 7:35. [PMID: 34460634 PMCID: PMC8321270 DOI: 10.3390/jimaging7020035] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Revised: 01/28/2021] [Accepted: 02/05/2021] [Indexed: 11/25/2022] Open
Abstract
The prevailing approach for three-dimensional (3D) medical image segmentation is to use convolutional networks. Recently, deep learning methods have achieved human-level performance in several important applied problems, such as volumetry for lung-cancer diagnosis or delineation for radiation therapy planning. However, state-of-the-art architectures, such as U-Net and DeepMedic, are computationally heavy and require workstations accelerated with graphics processing units for fast inference. However, scarce research has been conducted concerning enabling fast central processing unit computations for such networks. Our paper fills this gap. We propose a new segmentation method with a human-like technique to segment a 3D study. First, we analyze the image at a small scale to identify areas of interest and then process only relevant feature-map patches. Our method not only reduces the inference time from 10 min to 15 s but also preserves state-of-the-art segmentation quality, as we illustrate in the set of experiments with two large datasets.
Collapse
Affiliation(s)
- Boris Shirokikh
- Center for Neurobiology and Brain Restoration, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia; (A.S.); (M.B.)
| | - Alexey Shevtsov
- Center for Neurobiology and Brain Restoration, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia; (A.S.); (M.B.)
- Sector of Data Analysis for Neuroscience, Kharkevich Institute for Information Transmission Problems, 127051 Moscow, Russia;
- Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, 141701 Moscow, Russia
| | | | - Egor Krivov
- Sector of Data Analysis for Neuroscience, Kharkevich Institute for Information Transmission Problems, 127051 Moscow, Russia;
- Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, 141701 Moscow, Russia
| | | | - Andrey Golanov
- Department of Radiosurgery and Radiation, Burdenko Neurosurgery Institute, 125047 Moscow, Russia;
| | - Victor Gombolevskiy
- Medical Research Department, Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies of the Department of Health Care of Moscow, 127051 Moscow, Russia; (V.G.); (S.M.)
| | - Sergey Morozov
- Medical Research Department, Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies of the Department of Health Care of Moscow, 127051 Moscow, Russia; (V.G.); (S.M.)
| | - Mikhail Belyaev
- Center for Neurobiology and Brain Restoration, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia; (A.S.); (M.B.)
| |
Collapse
|
46
|
Dick J, Darras KE, Lexa FJ, Denton E, Ehara S, Galloway H, Jankharia B, Kassing P, Kumamaru KK, Mildenberger P, Morozov S, Pyatigorskaya N, Song B, Sosna J, van Buchem M, Forster BB. An International Survey of Quality and Safety Programs in Radiology. Can Assoc Radiol J 2021; 72:135-141. [PMID: 32066249 DOI: 10.1177/0846537119899195] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
PURPOSE The aim of this study was to determine the status of radiology quality improvement programs in a variety of selected nations worldwide. METHODS A survey was developed by select members of the International Economics Committee of the American College of Radiology on quality programs and was distributed to committee members. Members responded on behalf of their country. The 51-question survey asked about 12 different quality initiatives which were grouped into 4 themes: departments, users, equipment, and outcomes. Respondents reported whether a designated type of quality initiative was used in their country and answered subsequent questions further characterizing it. RESULTS The response rate was 100% and represented Australia, Canada, China, England, France, Germany, India, Israel, Japan, the Netherlands, Russia, and the United States. The most frequently reported quality initiatives were imaging appropriateness (91.7%) and disease registries (91.7%), followed by key performance indicators (83.3%) and morbidity and mortality rounds (83.3%). Peer review, equipment accreditation, radiation dose monitoring, and structured reporting were reported by 75.0% of respondents, followed by 58.3% of respondents for quality audits and critical incident reporting. The least frequently reported initiatives included Lean/Kaizen exercises and physician performance assessments, implemented by 25.0% of respondents. CONCLUSION There is considerable diversity in the quality programs used throughout the world, despite some influence by national and international organizations, from whom further guidance could increase uniformity and optimize patient care in radiology.
Collapse
Affiliation(s)
- Jeremy Dick
- University of British Columbia, Vancouver, British Columbia, Canada
| | - Kathryn E Darras
- University of British Columbia, Vancouver, British Columbia, Canada
- Department of Radiology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Frank J Lexa
- Department of Medical Imaging, 12216University of Arizona College of Medicine, Tucson, AZ, USA
- The Radiology Leadership Institute and Commission on Leadership and Practice Development, 72672American College of Radiology, Tucson, AZ, USA
| | - Erika Denton
- Norfolk & Norwich University Hospital, Norwich, Norfolk, United Kingdom
| | - Shigeru Ehara
- Department of Radiology, Tohoku Medical and Pharmaceutical University, Sendai, Tohoku, Japan
| | | | | | - Pam Kassing
- 72672American College of Radiology, Reston, VA, USA
| | | | - Peter Mildenberger
- Department of Radiology, 9182University Medical Center Mainz, Mainz, Germany
| | | | - Nadya Pyatigorskaya
- Department of Neuroradiology, 27063Sorbonne University, Hôpital de la Pitié-Salpêtrière, Paris, France
| | - Bin Song
- West China Hospital, 12530Sichuan University, Chengdu, Sichuan, China
| | - Jacob Sosna
- Department of Radiology, 58884Hadassah Hebrew University Medical Center, Jerusalem, Israel
| | - Marcus van Buchem
- Department of Radiology, 4501Leiden University Medical Center, Leiden, the Netherlands
| | - Bruce B Forster
- University of British Columbia, Vancouver, British Columbia, Canada
- Department of Radiology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
47
|
Adamczewski-Musch J, Arnold O, Behnke C, Belounnas A, Belyaev A, Berger-Chen JC, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Chlad L, Ciepal I, Deveaux C, Dreyer J, Epple E, Fabbietti L, Fateev O, Filip P, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gernhäuser R, Golosov O, Golubeva M, Greifenhagen R, Guber F, Gumberidze M, Harabasz S, Heinz T, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Kämpfer B, Karavicheva T, Kardan B, Koenig I, Koenig W, Kohls M, Kolb BW, Korcyl G, Kornakov G, Kornas F, Kotte R, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Malige A, Mamaev M, Mangiarotti A, Markert J, Matulewicz T, Maurus S, Metag V, Michel J, Mihaylov DM, Morozov S, Müntz C, Münzer R, Naumann L, Nowakowski K, Parpottas Y, Pechenov V, Pechenova O, Petukhov O, Piasecki K, Pietraszko J, Przygoda W, Pysz K, Ramos S, Ramstein B, Rathod N, Reshetin A, Rodriguez-Ramos P, Rosier P, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Schwab E, Scozzi F, Seck F, Sellheim P, Selyuzhenkov I, Siebenson J, Silva L, Singh U, Smyrski J, Sobolev YG, Spataro S, Spies S, Ströbele H, Stroth J, Sturm C, Svoboda O, Szala M, Tlusty P, Traxler M, Tsertos H, Usenko E, Wagner V, Wendisch C, Wiebusch MG, Wirth J, Wójcik D, Zanevsky Y, Zumbruch P. Directed, Elliptic, and Higher Order Flow Harmonics of Protons, Deuterons, and Tritons in Au+Au Collisions at sqrt[s_{NN}]=2.4 GeV. Phys Rev Lett 2020; 125:262301. [PMID: 33449792 DOI: 10.1103/physrevlett.125.262301] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 10/07/2020] [Accepted: 11/29/2020] [Indexed: 06/12/2023]
Abstract
Flow coefficients v_{n} of the orders n=1-6 are measured with the High-Acceptance DiElectron Spectrometer (HADES) at GSI for protons, deuterons, and tritons as a function of centrality, transverse momentum, and rapidity in Au+Au collisions at sqrt[s_{NN}]=2.4 GeV. Combining the information from the flow coefficients of all orders allows us to construct for the first time, at collision energies of a few GeV, a multidifferential picture of the angular emission pattern of these particles. It reflects the complicated interplay between the effect of the central fireball pressure on the emission of particles and their subsequent interaction with spectator matter. The high precision information on higher order flow coefficients is a major step forward in constraining the equation of state of dense baryonic matter.
Collapse
Affiliation(s)
- J Adamczewski-Musch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Arnold
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - C Behnke
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - A Belounnas
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - A Belyaev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - J C Berger-Chen
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Blanco
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - C Blume
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - M Böhmer
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - P Bordalo
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - S Chernenko
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - L Chlad
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - I Ciepal
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | - C Deveaux
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - J Dreyer
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - E Epple
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - L Fabbietti
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - O Fateev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - P Filip
- Institute of Physics, Slovak Academy of Sciences, 84228 Bratislava, Slovakia
| | - P Fonte
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - C Franco
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - J Friese
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - I Fröhlich
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - T Galatyuk
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - J A Garzón
- LabCAF. F. Física, Universidad de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - R Gernhäuser
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - O Golosov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - M Golubeva
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - R Greifenhagen
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - F Guber
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - M Gumberidze
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - S Harabasz
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - T Heinz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - T Hennino
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - S Hlavac
- Institute of Physics, Slovak Academy of Sciences, 84228 Bratislava, Slovakia
| | - C Höhne
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - R Holzmann
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - A Ierusalimov
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - A Ivashkin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - B Kämpfer
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - T Karavicheva
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - B Kardan
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - I Koenig
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - W Koenig
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - M Kohls
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - B W Kolb
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - G Korcyl
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - G Kornakov
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - F Kornas
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - R Kotte
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - A Kugler
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - T Kunz
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Kurepin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - A Kurilkin
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - P Kurilkin
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - V Ladygin
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - R Lalik
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - K Lapidus
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Lebedev
- Institute of Theoretical and Experimental Physics, 117218 Moscow, Russia
| | - L Lopes
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - M Lorenz
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - T Mahmoud
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - L Maier
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Malige
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - M Mamaev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - A Mangiarotti
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - J Markert
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - T Matulewicz
- Uniwersytet Warszawski, Wydział Fizyki, Instytut Fizyki Doświadczalnej, 02-093 Warszawa, Poland
| | - S Maurus
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - V Metag
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - J Michel
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - D M Mihaylov
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - S Morozov
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - C Müntz
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - R Münzer
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - L Naumann
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - K Nowakowski
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - Y Parpottas
- Department of Physics, University of Cyprus, 1678 Nicosia, Cyprus
| | - V Pechenov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Pechenova
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Petukhov
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - K Piasecki
- Uniwersytet Warszawski, Wydział Fizyki, Instytut Fizyki Doświadczalnej, 02-093 Warszawa, Poland
| | - J Pietraszko
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - W Przygoda
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - K Pysz
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | - S Ramos
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - B Ramstein
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - N Rathod
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - A Reshetin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - P Rodriguez-Ramos
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - P Rosier
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - A Rost
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - A Rustamov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - A Sadovsky
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - P Salabura
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - T Scheib
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - H Schuldes
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - E Schwab
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - F Scozzi
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - F Seck
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - P Sellheim
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - I Selyuzhenkov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - J Siebenson
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - L Silva
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - U Singh
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - J Smyrski
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - Yu G Sobolev
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - S Spataro
- Dipartimento di Fisica and INFN, Università di Torino, 10125 Torino, Italy
| | - S Spies
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - H Ströbele
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - J Stroth
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - C Sturm
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Svoboda
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - M Szala
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - P Tlusty
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - M Traxler
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - H Tsertos
- Department of Physics, University of Cyprus, 1678 Nicosia, Cyprus
| | - E Usenko
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - V Wagner
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - C Wendisch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - M G Wiebusch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - J Wirth
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - D Wójcik
- Uniwersytet Warszawski, Wydział Fizyki, Instytut Fizyki Doświadczalnej, 02-093 Warszawa, Poland
| | - Y Zanevsky
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - P Zumbruch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| |
Collapse
|
48
|
Skurikhin E, Nebolsin V, Widera D, Ermakova N, Pershina O, Pakhomova A, Krupin V, Pan E, Zhukova M, Novikov F, Sandrikina L, Morozov S, Kubatiev A, Dygai A. Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis. Int J Mol Sci 2020; 21:ijms21218380. [PMID: 33171668 PMCID: PMC7664690 DOI: 10.3390/ijms21218380] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Revised: 10/26/2020] [Accepted: 11/06/2020] [Indexed: 12/16/2022] Open
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease characterized by interstitial fibrosis and progressive respiratory failure. Pirfenidone and nintedanib slow down but do not stop the progression of IPF. Thus, new compounds with high antifibrotic activity and simultaneously regenerative activity are an unmet clinical need. Recently, we showed that Treamid can help restoring the pancreas and testicular tissue in mice with metabolic disorders. We hypothesized that Treamid may be effective in antifibrotic therapy and regeneration of damaged lung tissue in pulmonary fibrosis. In this study, experiments were performed on male C57BL/6 mice with bleomycin-induced pulmonary fibrosis. We applied histological and immunohistochemical methods, ELISA, and assessed the expression of markers of endothelial and epithelial cells in primary cultures of CD31+ and CD326+ lung cells. Finally, we evaluated esterase activity and apoptosis of lung cells in vitro. Our data indicate that Treamid exhibits antifibrotic activity in mice with pulmonary fibrosis and has a positive effect on capillaries of the lungs. Treamid also increases the number of endothelial progenitor cells in the lungs of animals with pulmonary fibrosis. Lastly, Treamid increases esterase activity and decreases apoptosis of CD31+ lung cells in vitro. Based on these findings, we suggest that Treamid may represent a promising compound for the development of new antifibrotic agents, which are capable of stimulating regeneration of lung endothelium in IPF patients.
Collapse
Affiliation(s)
- Evgenii Skurikhin
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
- Correspondence: ; Tel.: +7-3822-418-375
| | | | - Darius Widera
- Stem Cell Biology and Regenerative Medicine Group, School of Pharmacy, University of Reading, Whiteknights campus, Reading RG6 6AP, UK;
| | - Natalia Ermakova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
| | - Olga Pershina
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
| | - Angelina Pakhomova
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
| | - Vyacheslav Krupin
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
| | - Edgar Pan
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
| | - Mariia Zhukova
- Siberian State Medical University, 634028 Tomsk, Russia;
| | - Fedor Novikov
- “PHARMENTERPRISES” Ltd., 143026 Moscow, Russia; (V.N.); (F.N.)
| | - Lubov Sandrikina
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
| | - Sergey Morozov
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia; (S.M.); (A.K.)
| | - Aslan Kubatiev
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia; (S.M.); (A.K.)
| | - Alexander Dygai
- Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Lenin, 3, 634028 Tomsk, Russia; (N.E.); (O.P.); (A.P.); (V.K.); (E.P.); (L.S.); (A.D.)
- Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia; (S.M.); (A.K.)
| |
Collapse
|
49
|
Morozov S. Review of "Artificial intelligence for the study of colorectal cancer tissue slides". 2020. [DOI: 10.14322/publons.r9355296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
50
|
Salabura P, Adamczewski-Musch J, Arnoldi-Meadows B, Belounnas A, Belyaev A, Blanco A, Blume C, Böhmer M, Borisenko S, Chlad L, Chudoba P, Ciepał I, Dittert D, Dreyer J, Esmail W, Dürr M, Fabbietti L, Fateev S, Fonte P, Friese J, Fröhlich I, Förtsch J, Galatyuk T, Gernhäuser R, Golosov O, Golubeva M, Greifenhagen R, Guber F, Gumberidze M, Harabasz S, Hensch R, Höhne C, Holzmann R, Huck H, Ierusalimov A, Ivashkin A, Kämpfer B, Kampert KH, Kardan B, Koenig I, Koenig W, Kornakov G, Kornas F, Kotte R, Kozela A, Kres I, Kuboś J, Kugler A, Kulesa P, Ladygin V, Lalik R, Lebedev A, Lebedev S, Linev S, Lopes L, Lorenz M, Lykasov G, Mahmoud T, Malige A, Markert J, Matulewicz T, Maurus S, Metag V, Michel J, Morozov S, Müntz C, Naumann L, Nowakowski K, Otto JH, Patel V, Pauly C, Pechenov V, Pechenova O, Petukhov O, Pfeifer D, Piasecki K, Pietraszko J, Prozorov A, Przygoda W, Pysz K, Ramstein B, Rathod N, Reshetin A, Ritman L, Rodriguez-Ramos P, Rost A, Salabura P, Scozzi F, Seck F, Selyuzhenkov I, Shabanov I, Singh US, Smyrski J, Spies S, Ströbele H, Stroth J, Stumm J, Svoboda O, Szala M, Tlusty P, Traxler M, Ungethüm C, Vazquez-Doce O, Wagner V, Weber A, Wendisch C, Wiebusch M, Wintz P, Wirth J, Zhilin A, Zumbruch P. Exploring time like tranistions in pp, πp and AA reactions with HADES. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202024101013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Radiative transition of an excited baryon to a nucleon with emission of a virtual massive photon converting to dielectron pair (Dalitz decays) provides important information about baryon-photon coupling at low q2 in timelike region. A prominent enhancement in the respective electromagnetic transition Form Factors (etFF) at q2 near vector mesons ρ/ω poles has been predicted by various calculations reflecting strong baryon-vector meson couplings. The understanding of these couplings is also of primary importance for the interpretation of the emissivity of QCD matter studied in heavy ion collisions via dilepton emission. Dedicated measurements of baryon Dalitz decays in proton-proton and pion-proton scattering with HADES detector at GSI/FAIR are presented and discussed. The relevance of these studies for the interpretation of results obtained from heavy ion reactions is elucidated on the example of the HADES results.
Collapse
|